false Q1 --12-31 0001750106 262782 0001750106 2024-01-01 2024-03-31 0001750106 2024-05-15 0001750106 2024-03-31 0001750106 2023-12-31 0001750106 us-gaap:RelatedPartyMember 2024-03-31 0001750106 us-gaap:RelatedPartyMember 2023-12-31 0001750106 us-gaap:NonrelatedPartyMember 2024-03-31 0001750106 us-gaap:NonrelatedPartyMember 2023-12-31 0001750106 2023-01-01 2023-03-31 0001750106 AEI:RentalMember 2024-01-01 2024-03-31 0001750106 AEI:RentalMember 2023-01-01 2023-03-31 0001750106 AEI:PropertyMember 2024-01-01 2024-03-31 0001750106 AEI:PropertyMember 2023-01-01 2023-03-31 0001750106 AEI:BiohealthMember 2024-01-01 2024-03-31 0001750106 AEI:BiohealthMember 2023-01-01 2023-03-31 0001750106 AEI:OtherMember 2024-01-01 2024-03-31 0001750106 AEI:OtherMember 2023-01-01 2023-03-31 0001750106 us-gaap:NonrelatedPartyMember 2024-01-01 2024-03-31 0001750106 us-gaap:NonrelatedPartyMember 2023-01-01 2023-03-31 0001750106 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001750106 us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-12-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-12-31 0001750106 us-gaap:CommonStockMember 2023-12-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001750106 us-gaap:RetainedEarningsMember 2023-12-31 0001750106 us-gaap:ParentMember 2023-12-31 0001750106 us-gaap:NoncontrollingInterestMember 2023-12-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001750106 us-gaap:CommonStockMember 2022-12-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001750106 us-gaap:RetainedEarningsMember 2022-12-31 0001750106 us-gaap:ParentMember 2022-12-31 0001750106 us-gaap:NoncontrollingInterestMember 2022-12-31 0001750106 2022-12-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-03-31 0001750106 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001750106 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001750106 us-gaap:ParentMember 2024-01-01 2024-03-31 0001750106 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001750106 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001750106 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001750106 us-gaap:ParentMember 2023-01-01 2023-03-31 0001750106 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-03-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-03-31 0001750106 us-gaap:CommonStockMember 2024-03-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001750106 us-gaap:RetainedEarningsMember 2024-03-31 0001750106 us-gaap:ParentMember 2024-03-31 0001750106 us-gaap:NoncontrollingInterestMember 2024-03-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001750106 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0001750106 us-gaap:CommonStockMember 2023-03-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001750106 us-gaap:RetainedEarningsMember 2023-03-31 0001750106 us-gaap:ParentMember 2023-03-31 0001750106 us-gaap:NoncontrollingInterestMember 2023-03-31 0001750106 2023-03-31 0001750106 AEI:AlsetInternationalMember 2022-10-04 0001750106 us-gaap:LandAndBuildingMember 2024-01-01 2024-03-31 0001750106 us-gaap:LandAndBuildingMember 2023-01-01 2023-12-31 0001750106 us-gaap:LandAndBuildingMember 2023-01-01 2023-03-31 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember srt:MinimumMember 2024-03-31 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember 2022-03-14 2022-03-15 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember 2023-12-14 2023-12-14 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember 2024-03-31 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember 2023-12-31 0001750106 AEI:BrokerageMember 2024-03-31 0001750106 AEI:BrokerageMember 2023-12-31 0001750106 AEI:HWHInternationalIncMember 2024-01-09 2024-01-09 0001750106 AEI:HWHInternationalIncMember us-gaap:InvestorMember 2024-01-09 2024-01-09 0001750106 AEI:HWHInternationalIncMember us-gaap:InvestorMember 2024-01-09 0001750106 AEI:HWHInternationalIncMember 2023-03-31 0001750106 AEI:HWHInternationalIncMember 2024-03-31 0001750106 AEI:AmarantusBioScienceHoldingsMember 2024-03-31 0001750106 AEI:AMBSAndHolistaMember 2024-03-31 0001750106 AEI:ValueExchangeInternationalMember 2021-04-10 2021-04-12 0001750106 AEI:ValueExchangeInternationalMember 2021-04-12 0001750106 2022-10-16 2022-10-17 0001750106 AEI:ValueExchangeInternationalMember 2023-09-06 2023-09-06 0001750106 AEI:ValueExchangeInternationalMember 2022-10-17 0001750106 AEI:SharingServicesGlobalCorpMember 2024-03-20 0001750106 AEI:SharingServicesGlobalCorpMember 2024-03-20 2024-03-20 0001750106 AEI:DocumentSecuritiesSystemsIncMember 2024-03-31 0001750106 AEI:DocumentSecuritiesSystemsIncMember 2023-12-31 0001750106 AEI:NewElectricCVCorporationMember 2024-03-31 0001750106 AEI:ValueExchangeInternationalIncMember 2024-03-31 0001750106 AEI:SHRGMember 2024-03-31 0001750106 2023-08-08 2023-08-08 0001750106 2023-01-01 2023-12-31 0001750106 AEI:NervotecPteLtdMember 2020-09-06 2020-09-08 0001750106 AEI:NervotecPteLtdMember 2020-09-08 0001750106 AEI:HytenGlobalThailandCoLtdMember 2020-09-28 2020-09-30 0001750106 AEI:HytenGlobalThailandCoLtdMember 2020-09-30 0001750106 AEI:KBeautyResearchLabCoLtdMember 2021-12-31 0001750106 AEI:LiquidValueAssetManagementPteLtdMember 2024-03-31 0001750106 AEI:DSSIncMember 2024-03-31 0001750106 AEI:AmericanMedicalREITIncMember 2024-03-31 0001750106 us-gaap:CommonStockMember 2021-03-12 2021-03-12 0001750106 AEI:SeriesACommonStockMember 2021-09-07 2021-09-08 0001750106 AEI:AmericanPacificFinancialIncMember 2021-09-07 2021-09-08 0001750106 AEI:AmericanPacificFinancialIncMember 2024-01-01 2024-03-31 0001750106 AEI:AmericanPacificFinancialIncMember 2023-01-01 2023-03-31 0001750106 AEI:AmericanPacificFinancialIncMember 2024-03-31 0001750106 AEI:AmericanPacificFinancialIncMember 2023-03-31 0001750106 AEI:KetomeiPteLtdMember 2021-06-10 0001750106 AEI:KetomeiPteLtdMember 2022-06-01 2022-06-10 0001750106 AEI:KetomeiPteLtdMember 2022-06-10 0001750106 AEI:KetomeiPteLtdMember 2023-12-31 0001750106 AEI:KetomeiPteLtdMember 2024-02-20 0001750106 AEI:SeDCapitalPteLtdMember AEI:StockPurchaseAgreementMember 2023-05-22 2023-05-22 0001750106 AEI:SeDCapitalPteLtdMember AEI:StockPurchaseAgreementMember 2023-05-22 0001750106 AEI:SeDCapitalPteLtdMember AEI:StockPurchaseAgreementMember 2023-05-22 2023-05-22 0001750106 AEI:SeDCapitalPteLtdMember AEI:StockPurchaseAgreementMember 2024-01-01 2024-03-31 0001750106 AEI:SeDCapitalPteLtdMember AEI:StockPurchaseAgreementMember 2023-01-01 2023-03-31 0001750106 AEI:SeDCapitalPteLtdMember AEI:StockPurchaseAgreementMember 2024-03-31 0001750106 AEI:SeDCapitalPteLtdMember AEI:StockPurchaseAgreementMember 2023-03-31 0001750106 AEI:VectorComcoLtdMember 2021-02-26 0001750106 AEI:VectorComcoLtdMember 2023-12-31 0001750106 srt:MinimumMember 2024-03-31 0001750106 srt:MaximumMember 2024-03-31 0001750106 2023-07-14 0001750106 AEI:BlackOakMember 2024-03-31 0001750106 AEI:BlackOakMember 2023-03-31 0001750106 AEI:DeferredRevenueMember 2024-03-31 0001750106 AEI:DeferredRevenueMember 2023-12-31 0001750106 AEI:DeferredRevenueMember 2022-01-01 2022-12-31 0001750106 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001750106 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001750106 AEI:AlsetGlobalPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetGlobalPteLtdMember 2024-03-31 0001750106 AEI:AlsetGlobalPteLtdMember 2023-12-31 0001750106 AEI:AlsetBusinessDevelopmentPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetBusinessDevelopmentPteLtdMember 2024-03-31 0001750106 AEI:AlsetBusinessDevelopmentPteLtdMember 2023-12-31 0001750106 AEI:GlobaleHealthLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:GlobaleHealthLimitedMember 2024-03-31 0001750106 AEI:GlobaleHealthLimitedMember 2023-12-31 0001750106 AEI:AlsetInternationalLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetInternationalLimitedMember 2024-03-31 0001750106 AEI:AlsetInternationalLimitedMember 2023-12-31 0001750106 AEI:SingaporeConstructionDevelopmentPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:SingaporeConstructionDevelopmentPteLtdMember 2024-03-31 0001750106 AEI:SingaporeConstructionDevelopmentPteLtdMember 2023-12-31 0001750106 AEI:SingaporeConstructionPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:SingaporeConstructionPteLtdMember 2024-03-31 0001750106 AEI:SingaporeConstructionPteLtdMember 2023-12-31 0001750106 AEI:GlobalBioMedicalPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:GlobalBioMedicalPteLtdMember 2024-03-31 0001750106 AEI:GlobalBioMedicalPteLtdMember 2023-12-31 0001750106 AEI:HealthWealthHappinessPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HealthWealthHappinessPteLtdMember 2024-03-31 0001750106 AEI:HealthWealthHappinessPteLtdMember 2023-12-31 0001750106 AEI:SeDCapitalPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:SeDCapitalPteLtdMember 2024-03-31 0001750106 AEI:SeDCapitalPteLtdMember 2023-12-31 0001750106 AEI:LiquidValueAssetManagementPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:LiquidValueAssetManagementPteLtdMember 2024-03-31 0001750106 AEI:LiquidValueAssetManagementPteLtdMember 2023-12-31 0001750106 AEI:AlsetSolarLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetSolarLimitedMember 2024-03-31 0001750106 AEI:AlsetSolarLimitedMember 2023-12-31 0001750106 AEI:AlsetFBOnePteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetFBOnePteLtdMember 2024-03-31 0001750106 AEI:AlsetFBOnePteLtdMember 2023-12-31 0001750106 AEI:BMICapitalPartnersInternationalLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:BMICapitalPartnersInternationalLimitedMember 2024-03-31 0001750106 AEI:BMICapitalPartnersInternationalLimitedMember 2023-12-31 0001750106 AEI:SeDPerthPtyLtdMember 2024-01-01 2024-03-31 0001750106 AEI:SeDPerthPtyLtdMember 2024-03-31 0001750106 AEI:SeDPerthPtyLtdMember 2023-12-31 0001750106 AEI:SeDIntelligentHomeIncMember 2024-01-01 2024-03-31 0001750106 AEI:SeDIntelligentHomeIncMember 2024-03-31 0001750106 AEI:SeDIntelligentHomeIncMember 2023-12-31 0001750106 AEI:LiquidValueDevelopmentIncMember 2024-01-01 2024-03-31 0001750106 AEI:LiquidValueDevelopmentIncMember 2024-03-31 0001750106 AEI:LiquidValueDevelopmentIncMember 2023-12-31 0001750106 AEI:AlsetEHomeIncMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetEHomeIncMember 2024-03-31 0001750106 AEI:AlsetEHomeIncMember 2023-12-31 0001750106 AEI:SeDUSALLCMember 2024-01-01 2024-03-31 0001750106 AEI:SeDUSALLCMember 2024-03-31 0001750106 AEI:SeDUSALLCMember 2023-12-31 0001750106 AEI:OneHundredFiftyBlackOakGPIncMember 2024-01-01 2024-03-31 0001750106 AEI:OneHundredFiftyBlackOakGPIncMember 2024-03-31 0001750106 AEI:OneHundredFiftyBlackOakGPIncMember 2023-12-31 0001750106 AEI:SeDDevelopmentUSAIncMember 2024-01-01 2024-03-31 0001750106 AEI:SeDDevelopmentUSAIncMember 2024-03-31 0001750106 AEI:SeDDevelopmentUSAIncMember 2023-12-31 0001750106 AEI:OneHundredFiftyCCMBlackOakLtdMember 2024-01-01 2024-03-31 0001750106 AEI:OneHundredFiftyCCMBlackOakLtdMember 2024-03-31 0001750106 AEI:OneHundredFiftyCCMBlackOakLtdMember 2023-12-31 0001750106 AEI:SeDTexasHomeLLCMember 2024-01-01 2024-03-31 0001750106 AEI:SeDTexasHomeLLCMember 2024-03-31 0001750106 AEI:SeDTexasHomeLLCMember 2023-12-31 0001750106 AEI:SeDBallengerLLCMember 2024-01-01 2024-03-31 0001750106 AEI:SeDBallengerLLCMember 2024-03-31 0001750106 AEI:SeDBallengerLLCMember 2023-12-31 0001750106 AEI:SeDMarylandDevelopmentLLCMember 2024-01-01 2024-03-31 0001750106 AEI:SeDMarylandDevelopmentLLCMember 2024-03-31 0001750106 AEI:SeDMarylandDevelopmentLLCMember 2023-12-31 0001750106 AEI:SeDDevelopmentManagementLLCMember 2024-01-01 2024-03-31 0001750106 AEI:SeDDevelopmentManagementLLCMember 2024-03-31 0001750106 AEI:SeDDevelopmentManagementLLCMember 2023-12-31 0001750106 AEI:SeDBuilderLLCMember 2024-01-01 2024-03-31 0001750106 AEI:SeDBuilderLLCMember 2024-03-31 0001750106 AEI:SeDBuilderLLCMember 2023-12-31 0001750106 AEI:HapiMetaverseIncMember 2024-01-01 2024-03-31 0001750106 AEI:HapiMetaverseIncMember 2024-03-31 0001750106 AEI:HapiMetaverseIncMember 2023-12-31 0001750106 AEI:HotAppBlockChainPte.LtdMember 2024-01-01 2024-03-31 0001750106 AEI:HotAppBlockChainPte.LtdMember 2024-03-31 0001750106 AEI:HotAppBlockChainPte.LtdMember 2023-12-31 0001750106 AEI:HotAppInternationalLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:HotAppInternationalLimitedMember 2024-03-31 0001750106 AEI:HotAppInternationalLimitedMember 2023-12-31 0001750106 AEI:SeDREITIncMember 2024-01-01 2024-03-31 0001750106 AEI:SeDREITIncMember 2024-03-31 0001750106 AEI:SeDREITIncMember 2023-12-31 0001750106 AEI:HWHWorldIncMember 2024-01-01 2024-03-31 0001750106 AEI:HWHWorldIncMember 2024-03-31 0001750106 AEI:HWHWorldIncMember 2023-12-31 0001750106 AEI:HWHWorldPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HWHWorldPteLtdMember 2024-03-31 0001750106 AEI:HWHWorldPteLtdMember 2023-12-31 0001750106 AEI:UBeautyLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:UBeautyLimitedMember 2024-03-31 0001750106 AEI:UBeautyLimitedMember 2023-12-31 0001750106 AEI:HWHWorldLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:HWHWorldLimitedMember 2024-03-31 0001750106 AEI:HWHWorldLimitedMember 2023-12-31 0001750106 AEI:HWHWorldIncOneMember 2024-01-01 2024-03-31 0001750106 AEI:HWHWorldIncOneMember 2024-03-31 0001750106 AEI:HWHWorldIncOneMember 2023-12-31 0001750106 AEI:AlsetEnergyIncMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetEnergyIncMember 2024-03-31 0001750106 AEI:AlsetEnergyIncMember 2023-12-31 0001750106 AEI:NewRetailAIIncMember 2024-01-01 2024-03-31 0001750106 AEI:NewRetailAIIncMember 2024-03-31 0001750106 AEI:NewRetailAIIncMember 2023-12-31 0001750106 AEI:BioHealthWaterIncMember 2024-01-01 2024-03-31 0001750106 AEI:BioHealthWaterIncMember 2024-03-31 0001750106 AEI:BioHealthWaterIncMember 2023-12-31 0001750106 AEI:ImpactBioHealthPte.LtdMember 2024-01-01 2024-03-31 0001750106 AEI:ImpactBioHealthPte.LtdMember 2024-03-31 0001750106 AEI:ImpactBioHealthPte.LtdMember 2023-12-31 0001750106 AEI:AmericanHomeREITIncMember 2024-01-01 2024-03-31 0001750106 AEI:AmericanHomeREITIncMember 2024-03-31 0001750106 AEI:AmericanHomeREITIncMember 2023-12-31 0001750106 AEI:AlsetSolarIncMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetSolarIncMember 2024-03-31 0001750106 AEI:AlsetSolarIncMember 2023-12-31 0001750106 AEI:HWHKORIncMember 2024-01-01 2024-03-31 0001750106 AEI:HWHKORIncMember 2024-03-31 0001750106 AEI:HWHKORIncMember 2023-12-31 0001750106 AEI:AlsetCapitalIncMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetCapitalIncMember 2024-03-31 0001750106 AEI:AlsetCapitalIncMember 2023-12-31 0001750106 AEI:HapiCafeInTexasMember 2024-01-01 2024-03-31 0001750106 AEI:HapiCafeInTexasMember 2024-03-31 0001750106 AEI:HapiCafeInTexasMember 2023-12-31 0001750106 AEI:HWHSPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HWHSPteLtdMember 2024-03-31 0001750106 AEI:HWHSPteLtdMember 2023-12-31 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2024-03-31 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2023-12-31 0001750106 AEI:LiquidValueDevelopmentLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:LiquidValueDevelopmentLimitedMember 2024-03-31 0001750106 AEI:LiquidValueDevelopmentLimitedMember 2023-12-31 0001750106 AEI:AlsetFBHoldingsPteIncMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetFBHoldingsPteIncMember 2024-03-31 0001750106 AEI:AlsetFBHoldingsPteIncMember 2023-12-31 0001750106 AEI:CredasCapitalPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:CredasCapitalPteLtdMember 2024-03-31 0001750106 AEI:CredasCapitalPteLtdMember 2023-12-31 0001750106 AEI:CredasCapitalGmbhMember 2024-01-01 2024-03-31 0001750106 AEI:CredasCapitalGmbhMember 2024-03-31 0001750106 AEI:CredasCapitalGmbhMember 2023-12-31 0001750106 AEI:SmartRewardExpressLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:SmartRewardExpressLimitedMember 2024-03-31 0001750106 AEI:SmartRewardExpressLimitedMember 2023-12-31 0001750106 AEI:AHRTexasTwoLLCMember 2024-01-01 2024-03-31 0001750106 AEI:AHRTexasTwoLLCMember 2024-03-31 0001750106 AEI:AHRTexasTwoLLCMember 2023-12-31 0001750106 AEI:AHRBlackOakOneLLCMember 2024-01-01 2024-03-31 0001750106 AEI:AHRBlackOakOneLLCMember 2024-03-31 0001750106 AEI:AHRBlackOakOneLLCMember 2023-12-31 0001750106 AEI:AHRTexasThreeLLCMember 2024-01-01 2024-03-31 0001750106 AEI:AHRTexasThreeLLCMember 2024-03-31 0001750106 AEI:AHRTexasThreeLLCMember 2023-12-31 0001750106 AEI:HapiCafeKoreaIncMember 2024-01-01 2024-03-31 0001750106 AEI:HapiCafeKoreaIncMember 2024-03-31 0001750106 AEI:HapiCafeKoreaIncMember 2023-12-31 0001750106 AEI:AlsetManagementGroupIncMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetManagementGroupIncMember 2024-03-31 0001750106 AEI:AlsetManagementGroupIncMember 2023-12-31 0001750106 AEI:AlsetAcquisitionSponsorLLCMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetAcquisitionSponsorLLCMember 2024-03-31 0001750106 AEI:AlsetAcquisitionSponsorLLCMember 2023-12-31 0001750106 AEI:HWHInternationalIncMember 2024-01-01 2024-03-31 0001750106 AEI:HWHInternationalIncMember 2023-12-31 0001750106 AEI:AlsetSpacGroupIncMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetSpacGroupIncMember 2024-03-31 0001750106 AEI:AlsetSpacGroupIncMember 2023-12-31 0001750106 AEI:AlseteVehiclePteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:AlseteVehiclePteLtdMember 2024-03-31 0001750106 AEI:AlseteVehiclePteLtdMember 2023-12-31 0001750106 AEI:HapiTravelPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HapiTravelPteLtdMember 2024-03-31 0001750106 AEI:HapiTravelPteLtdMember 2023-12-31 0001750106 AEI:HapiWealthBuilderPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HapiWealthBuilderPteLtdMember 2024-03-31 0001750106 AEI:HapiWealthBuilderPteLtdMember 2023-12-31 0001750106 AEI:HWHMarketingPlacePteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HWHInternationalIncNevadaMember 2024-03-31 0001750106 AEI:HWHInternationalIncNevadaMember 2023-12-31 0001750106 AEI:HWHInternationalIncNevadaMember 2024-01-01 2024-03-31 0001750106 AEI:HapiCafeSGPteMember 2024-03-31 0001750106 AEI:HapiCafeSGPteMember 2024-01-01 2024-03-31 0001750106 AEI:HapiCafeSGPteMember 2023-12-31 0001750106 AEI:AlsetReitsIncMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetReitsIncMember 2024-03-31 0001750106 AEI:AlsetReitsIncMember 2023-12-31 0001750106 AEI:HapiMetaverseIncTexasMember 2024-01-01 2024-03-31 0001750106 AEI:HapiMetaverseIncTexasMember 2024-03-31 0001750106 AEI:HapiMetaverseIncTexasMember 2023-12-31 0001750106 AEI:HapiCafeLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:HapiCafeLimitedMember 2024-03-31 0001750106 AEI:HapiCafeLimitedMember 2023-12-31 0001750106 AEI:MOCHKltdMember 2024-01-01 2024-03-31 0001750106 AEI:MOCHKltdMember 2024-03-31 0001750106 AEI:MOCHKltdMember 2023-12-31 0001750106 AEI:AHRTexasFourLLCMember 2024-01-01 2024-03-31 0001750106 AEI:AHRTexasFourLLCMember 2024-03-31 0001750106 AEI:AHRTexasFourLLCMember 2023-12-31 0001750106 AEI:AlsetFBPLQPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:AlsetFBPLQPteLtdMember 2024-03-31 0001750106 AEI:AlsetFBPLQPteLtdMember 2023-12-31 0001750106 AEI:HapiCafeSdnBhdMember 2024-01-01 2024-03-31 0001750106 AEI:HapiCafeSdnBhdMember 2024-03-31 0001750106 AEI:HapiCafeSdnBhdMember 2023-12-31 0001750106 AEI:ShenzhenLeyouyouCateringManagementCoLtdMember 2024-01-01 2024-03-31 0001750106 AEI:ShenzhenLeyouyouCateringManagementCoLtdMember 2024-03-31 0001750106 AEI:ShenzhenLeyouyouCateringManagementCoLtdMember 2023-12-31 0001750106 AEI:DongguanLeyouyouCateringManagementCoLtdMember 2024-01-01 2024-03-31 0001750106 AEI:DongguanLeyouyouCateringManagementCoLtdMember 2024-03-31 0001750106 AEI:DongguanLeyouyouCateringManagementCoLtdMember 2023-12-31 0001750106 AEI:GuangzhoLeyouyouCateringManagementCoLtdMember 2024-01-01 2024-03-31 0001750106 AEI:GuangzhoLeyouyouCateringManagementCoLtdMember 2024-03-31 0001750106 AEI:GuangzhoLeyouyouCateringManagementCoLtdMember 2023-12-31 0001750106 AEI:HapiTravelLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HapiTravelLtdMember 2024-03-31 0001750106 AEI:HapiTravelLtdMember 2023-12-31 0001750106 AEI:HapiAcquisitionPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HapiAcquisitionPteLtdMember 2024-03-31 0001750106 AEI:HapiAcquisitionPteLtdMember 2023-12-31 0001750106 AEI:RoboticAiTradePteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:RoboticAiTradePteLtdMember 2024-03-31 0001750106 AEI:RoboticAiTradePteLtdMember 2023-12-31 0001750106 AEI:KetomeiPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:KetomeiPteLtdMember 2024-03-31 0001750106 AEI:KetomeiPteLtdMember 2023-12-31 0001750106 AEI:HapiMarketPlaceIncMember 2024-01-01 2024-03-31 0001750106 AEI:HapiMarketPlaceIncMember 2024-03-31 0001750106 AEI:HapiMarketPlaceIncMember 2023-12-31 0001750106 AEI:HapiCafeCoLtdMember 2024-01-01 2024-03-31 0001750106 AEI:HapiCafeCoLtdMember 2024-03-31 0001750106 AEI:HapiCafeCoLtdMember 2023-12-31 0001750106 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AEI:OneCustomerMember 2024-01-01 2024-03-31 0001750106 AEI:RealEstateSegmentMember 2024-01-01 2024-03-31 0001750106 AEI:DigitalTransformationTechnologyMember 2024-01-01 2024-03-31 0001750106 AEI:BiohealthBusinessMember 2024-01-01 2024-03-31 0001750106 AEI:OtherMember 2024-01-01 2024-03-31 0001750106 AEI:RealEstateSegmentMember 2023-01-01 2023-03-31 0001750106 AEI:DigitalTransformationTechnologyMember 2023-01-01 2023-03-31 0001750106 AEI:BiohealthBusinessMember 2023-01-01 2023-03-31 0001750106 AEI:OtherMember 2023-01-01 2023-03-31 0001750106 AEI:RealEstateSegmentMember 2024-03-31 0001750106 AEI:DigitalTransformationTechnologyMember 2024-03-31 0001750106 AEI:BiohealthBusinessMember 2024-03-31 0001750106 AEI:OtherMember 2024-03-31 0001750106 AEI:RealEstateSegmentMember 2023-12-31 0001750106 AEI:DigitalTransformationTechnologyMember 2023-12-31 0001750106 AEI:BiohealthBusinessMember 2023-12-31 0001750106 AEI:OtherMember 2023-12-31 0001750106 srt:SingleFamilyMember 2024-03-31 0001750106 srt:SingleFamilyMember 2023-12-31 0001750106 srt:SingleFamilyMember 2024-01-01 2024-03-31 0001750106 AEI:MotorVehicleLoansMember 2024-03-31 0001750106 AEI:MotorVehicleLoansMember 2023-12-31 0001750106 AEI:LoansforOperationsMember 2024-03-31 0001750106 AEI:LoansforOperationsMember 2023-12-31 0001750106 AEI:PromissoryNotetoEFHuttonMember 2024-03-31 0001750106 AEI:PromissoryNotetoEFHuttonMember 2023-12-31 0001750106 AEI:SeDMarylandDevelopmentLLCMember AEI:LoanAgreementMember 2019-04-17 0001750106 AEI:SeDMarylandDevelopmentLLCMember AEI:LoanAgreementMember 2019-04-15 2019-04-17 0001750106 2022-03-14 2022-03-15 0001750106 2022-03-15 0001750106 2023-12-14 2023-12-14 0001750106 AEI:HongLeongFinanceLimitedMember 2021-05-17 0001750106 AEI:HongLeongFinanceLimitedMember 2021-05-16 2021-05-17 0001750106 AEI:UnitedOverseasBankLimitedMember 2022-09-22 0001750106 AEI:UnitedOverseasBankLimitedMember 2022-09-22 2022-09-22 0001750106 2023-12-18 0001750106 AEI:HWHInternationalIncMember 2023-12-18 2023-12-18 0001750106 AEI:HWHInternationalIncMember 2023-12-18 0001750106 AEI:HWHInternationalIncMember 2023-12-17 2023-12-18 0001750106 AEI:HWHInternationalIncMember 2024-01-09 0001750106 AEI:HWHInternationalIncMember 2024-01-08 2024-01-09 0001750106 AEI:NewElectricCVCorporationMember 2020-07-16 2020-07-17 0001750106 AEI:NewElectricCVCorporationMember 2020-07-17 0001750106 AEI:NewElectricCVCorporationMember 2024-03-31 0001750106 AEI:NewElectricCVCorporationMember 2023-12-31 0001750106 AEI:NewElectricCVCorporationMember AEI:StockAndWarrantMember 2024-01-01 2024-03-31 0001750106 AEI:NewElectricCVCorporationMember 2024-01-01 2024-03-31 0001750106 AEI:NewElectricCVCorporationMember 2021-01-01 2021-12-31 0001750106 AEI:AlsetInternationalLimitedMember 2022-12-09 0001750106 AEI:AlsetEHomeIncMember 2022-12-09 0001750106 AEI:AlsetEHomeIncMember 2022-12-09 2022-12-09 0001750106 AEI:SharingServicesGlobalCorporationMember 2023-05-03 2023-05-04 0001750106 AEI:SharingServicesGlobalCorporationMember AEI:ChanHengFaiMember 2023-05-03 2023-05-04 0001750106 AEI:SharingServicesGlobalCorporationMember AEI:ChanHengFaiMember 2023-05-04 0001750106 AEI:AlsetCapitalAcquisitionCorpMember us-gaap:CommonClassAMember 2023-05-01 2023-05-01 0001750106 AEI:AlsetCapitalAcquisitionCorpMember us-gaap:CommonClassAMember 2023-05-01 0001750106 AEI:AlsetCapitalAcquisitionCorpMember us-gaap:CommonClassBMember 2023-05-01 2023-05-01 0001750106 AEI:AlsetCapitalAcquisitionCorpMember us-gaap:CommonClassBMember srt:MinimumMember 2023-05-01 2023-05-01 0001750106 AEI:AlsetCapitalAcquisitionCorpMember us-gaap:CommonClassBMember srt:MaximumMember 2023-05-01 2023-05-01 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2024-01-09 0001750106 AEI:MergerAgreementMember 2024-01-08 2024-01-09 0001750106 us-gaap:MajorityShareholderMember 2024-01-08 2024-01-09 0001750106 AEI:HWHInternationalIncMember 2024-01-09 0001750106 AEI:HWHInternationalIncMember 2024-01-09 0001750106 AEI:HapiTravelLtdMember 2023-06-14 2023-06-14 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2023-01-27 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2023-01-27 2023-01-27 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2023-02-23 0001750106 AEI:HapiMetaverseIncMember 2023-09-06 0001750106 AEI:HapiMetaverseIncMember 2023-09-06 2023-09-06 0001750106 AEI:HapiMetaverseIncMember srt:MaximumMember 2023-09-06 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2024-03-31 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2024-01-01 2024-03-31 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2023-12-31 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2023-01-01 2023-12-31 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2023-12-15 0001750106 AEI:HapiMetaverseIncAndNewElectricCVCropMember 2023-12-14 2023-12-14 0001750106 AEI:SharingServicesGlobalCorpMember 2024-01-17 0001750106 AEI:SharingServicesGlobalCorpMember 2024-01-17 2024-01-17 0001750106 AEI:SharingServicesGlobalCorpMember 2024-03-31 0001750106 AEI:HWHInternationalIncMember 2024-03-31 0001750106 AEI:HWHInternationalIncMember 2024-01-01 2024-03-31 0001750106 AEI:SentinelBrokersCompanyIncMember 2024-02-20 0001750106 AEI:SeDPerthPtyLtdMember us-gaap:RelatedPartyMember 2024-03-31 0001750106 AEI:SeDPerthPtyLtdMember us-gaap:RelatedPartyMember 2023-12-31 0001750106 AEI:HapiMetaverseIncMember us-gaap:RelatedPartyMember 2024-03-31 0001750106 AEI:HapiMetaverseIncMember us-gaap:RelatedPartyMember 2023-12-31 0001750106 AEI:MacKenzieEquityPartnersMember 2022-06-01 2022-06-30 0001750106 AEI:MacKenzieEquityPartnersMember 2024-01-01 2024-03-31 0001750106 AEI:MacKenzieEquityPartnersMember 2023-01-01 2023-03-31 0001750106 AEI:MacKenzieEquityPartnersMember us-gaap:RelatedPartyMember 2024-03-31 0001750106 AEI:MacKenzieEquityPartnersMember us-gaap:RelatedPartyMember 2023-12-31 0001750106 AEI:HapiCafeIncMember us-gaap:ConvertibleDebtMember 2023-12-31 0001750106 AEI:HapiTravelLtdMember 2023-12-31 0001750106 AEI:KetomeiMember 2022-03-21 0001750106 AEI:KetomeiPteLtdMember 2022-03-21 0001750106 AEI:KetomeiMember 2022-03-21 2022-03-21 0001750106 2022-03-21 0001750106 AEI:KetomeiMember 2022-07-27 2022-07-28 0001750106 AEI:KetomeiMember 2022-07-28 0001750106 AEI:HapiCafeIncMember 2022-07-27 2022-07-28 0001750106 AEI:HapiCafeIncMember us-gaap:ConvertibleDebtMember 2022-08-04 0001750106 AEI:HapiCafeIncMember 2022-07-28 0001750106 AEI:HapiCafeIncMember us-gaap:ConvertibleDebtMember 2023-08-31 0001750106 AEI:KetomeiMember us-gaap:ConvertibleDebtMember 2023-08-31 0001750106 AEI:KetomeiMember us-gaap:ConvertibleDebtMember 2023-08-12 0001750106 AEI:HapiCafeIncMember us-gaap:ConvertibleDebtMember 2022-07-28 2022-07-28 0001750106 AEI:KetomeiMember 2023-08-31 0001750106 AEI:KetomeiMember us-gaap:ConvertibleDebtMember 2023-10-31 0001750106 AEI:HapiCafeIncMember us-gaap:ConvertibleDebtMember 2023-10-26 0001750106 AEI:HapiCafeIncMember 2023-10-26 0001750106 AEI:KetomeiMember us-gaap:ConvertibleDebtMember 2023-12-31 0001750106 AEI:KetomeiMember 2024-02-20 0001750106 AEI:LiquidValueAssetManagementLimitedMember 2021-10-13 0001750106 AEI:LiquidValueAssetManagementLimitedMember 2021-10-13 2021-10-13 0001750106 AEI:LiquidValueAssetManagementLimitedMember 2024-03-31 0001750106 AEI:LiquidValueAssetManagementLimitedMember 2023-12-31 0001750106 AEI:LoansAgreementMember AEI:ValueExchangeInternationalIncMember 2023-09-28 2023-09-28 0001750106 AEI:LoansAgreementMember AEI:ValueExchangeInternationalIncMember 2023-09-28 0001750106 AEI:LoansAgreementMember 2024-01-01 2024-03-31 0001750106 AEI:LoansAgreementMember 2023-01-01 2023-12-31 0001750106 AEI:LoansAgreementMember AEI:ValueExchangeInternationalIncMember 2024-01-01 2024-03-31 0001750106 AEI:LoansAgreementMember AEI:ValueExchangeInternationalIncMember 2023-01-01 2023-12-31 0001750106 AEI:MOCHKLimitedMember 2022-10-04 0001750106 AEI:MOCHKLimitedMember 2022-10-04 2022-10-04 0001750106 us-gaap:GoodwillMember 2023-12-31 0001750106 us-gaap:GoodwillMember 2022-12-31 0001750106 us-gaap:GoodwillMember 2024-01-01 2024-03-31 0001750106 us-gaap:GoodwillMember 2023-01-01 2023-12-31 0001750106 us-gaap:GoodwillMember 2024-03-31 0001750106 2021-06-14 0001750106 us-gaap:SeriesAPreferredStockMember 2024-03-31 0001750106 us-gaap:SeriesBPreferredStockMember 2024-03-31 0001750106 2022-12-06 2022-12-06 0001750106 AEI:SeriesAConvertiblePreferredStockMember 2021-06-14 0001750106 us-gaap:SeriesBPreferredStockMember 2021-06-14 0001750106 us-gaap:CommonStockMember AEI:AegisCapitalCorpMember 2023-02-06 0001750106 us-gaap:CommonStockMember AEI:AegisCapitalCorpMember 2023-02-05 2023-02-06 0001750106 us-gaap:OverAllotmentOptionMember us-gaap:CommonStockMember 2023-02-05 2023-02-06 0001750106 AEI:MarchOfferingMember 2024-03-31 0001750106 us-gaap:CommonClassAMember 2023-12-31 0001750106 us-gaap:CommonClassAMember 2024-03-31 0001750106 AEI:SatisfactionAndDischargeOfIndebtednessAgreeementMember AEI:HWHInternationalIncMember 2023-12-18 2023-12-18 0001750106 AEI:SatisfactionAndDischargeOfIndebtednessAgreeementMember AEI:HWHInternationalIncMember 2023-12-18 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-12-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2023-12-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-01-01 2024-03-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2024-01-01 2024-03-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-03-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2024-03-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-12-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-03-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2023-01-01 2023-03-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-03-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2023-03-31 0001750106 AEI:SharingServicesConvertibleNoteMember 2024-01-01 2024-03-31 0001750106 AEI:NECVWarrantsMember 2024-01-01 2024-03-31 0001750106 AEI:VEIIWarrantsMember 2024-01-01 2024-03-31 0001750106 AEI:SHRGWarrantsMember 2024-01-01 2024-03-31 0001750106 AEI:InvestmentSecuritiesFairValueOptionMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:InvestmentSecuritiesFairValueOptionMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0001750106 AEI:InvestmentSecuritiesFairValueOptionMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 AEI:InvestmentSecuritiesFairValueOptionMember 2024-03-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 AEI:InvestmentsSecuritiesTradingMember 2024-03-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember 2024-03-31 0001750106 us-gaap:WarrantMember AEI:WarrantsVEIIMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:WarrantsVEIIMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:WarrantsVEIIMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:WarrantsVEIIMember 2024-03-31 0001750106 us-gaap:WarrantMember AEI:WarrantsSHRGMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:WarrantsSHRGMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:WarrantsSHRGMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:WarrantsSHRGMember 2024-03-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableVEIIMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableVEIIMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableVEIIMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableVEIIMember 2024-03-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableReceivableSHRGMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableReceivableSHRGMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableReceivableSHRGMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableReceivableSHRGMember 2024-03-31 0001750106 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001750106 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 AEI:InvestmentSecuritiesFairValueOptionMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:InvestmentSecuritiesFairValueOptionMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001750106 AEI:InvestmentSecuritiesFairValueOptionMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 AEI:InvestmentSecuritiesFairValueOptionMember 2023-12-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 AEI:InvestmentsSecuritiesTradingMember 2023-12-31 0001750106 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:ConvertibleNoteReceivableMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001750106 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 us-gaap:NotesReceivableMember 2023-12-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember 2023-12-31 0001750106 us-gaap:WarrantMember AEI:WarrantsVEIIMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:WarrantsVEIIMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:WarrantsVEIIMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:WarrantsVEIIMember 2023-12-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableVEIIMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableVEIIMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableVEIIMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 us-gaap:WarrantMember AEI:ConvertibleLoanReceivableVEIIMember 2023-12-31 0001750106 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001750106 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 AEI:NewElectricCVCorporationMember 2020-07-17 0001750106 AEI:NewElectricCVCorporationMember 2020-07-16 2020-07-17 0001750106 AEI:NewElectricCVCorporationMember 2021-01-01 2021-12-31 0001750106 AEI:NewElectricCVCorporationMember 2021-12-31 0001750106 AEI:NewElectricCVCorporationMember 2022-12-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember 2024-01-01 2024-03-31 0001750106 us-gaap:WarrantMember AEI:NewElectricCVCorporationMember 2023-01-01 2023-12-31 0001750106 AEI:AmericanMedicalREITIncMember 2024-01-01 2024-03-31 0001750106 AEI:AmericanMedicalREITIncMember 2023-01-01 2023-12-31 0001750106 AEI:SHRGMember AEI:SecuritiesPurchaseAgreementMember AEI:ConvertiblePromissoryNoteMember 2024-03-20 2024-03-20 0001750106 AEI:SHRGMember AEI:SecuritiesPurchaseAgreementMember AEI:ConvertiblePromissoryNoteMember 2024-03-20 0001750106 AEI:DocumentSecuritiesSystemsIncMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:DocumentSecuritiesSystemsIncMember us-gaap:FairValueInputsLevel1Member 2024-01-01 2024-03-31 0001750106 AEI:TradingStockMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:TradingStockMember us-gaap:FairValueInputsLevel1Member 2024-01-01 2024-03-31 0001750106 AEI:AmarantusBioScienceHoldingsMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:AmarantusBioScienceHoldingsMember us-gaap:FairValueInputsLevel1Member 2024-01-01 2024-03-31 0001750106 AEI:HolistaCollTechLimitedMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:HolistaCollTechLimitedMember us-gaap:FairValueInputsLevel1Member 2024-01-01 2024-03-31 0001750106 AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel1Member 2024-01-01 2024-03-31 0001750106 AEI:ValueExchangeInternationalIncMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:ValueExchangeInternationalIncMember us-gaap:FairValueInputsLevel1Member 2024-01-01 2024-03-31 0001750106 AEI:SharingServicesGlobalCorporationMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:SharingServicesGlobalCorporationMember us-gaap:FairValueInputsLevel1Member 2024-01-01 2024-03-31 0001750106 AEI:TradingStocksMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0001750106 AEI:NervotecPteLtdMember 2024-03-31 0001750106 AEI:NervotecPteLtdMember 2024-01-01 2024-03-31 0001750106 AEI:UBeautyLimitedMember 2024-03-31 0001750106 AEI:UBeautyLimitedMember 2024-01-01 2024-03-31 0001750106 AEI:DocumentSecuritiesSystemsIncMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:DocumentSecuritiesSystemsIncMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-12-31 0001750106 AEI:TradingStockMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:TradingStockMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-12-31 0001750106 AEI:AmarantusBioScienceHoldingsMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:AmarantusBioScienceHoldingsMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-12-31 0001750106 AEI:HolistaCollTechLimitedMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:HolistaCollTechLimitedMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-12-31 0001750106 AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:NewElectricCVCorporationMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-12-31 0001750106 AEI:ValueExchangeInternationalIncMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:ValueExchangeInternationalIncMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-12-31 0001750106 AEI:SharingServicesGlobalCorporationMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:SharingServicesGlobalCorporationMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-12-31 0001750106 AEI:TradingStocksMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001750106 AEI:NervotecPteLtdMember 2023-12-31 0001750106 AEI:NervotecPteLtdMember 2023-01-01 2023-12-31 0001750106 AEI:UBeautyLimitedMember 2023-12-31 0001750106 AEI:UBeautyLimitedMember 2023-01-01 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember AEI:NewElectricCVCorporationMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember AEI:NewElectricCVCorporationMember 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member AEI:NewElectricCVCorporationMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member AEI:NewElectricCVCorporationMember 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member AEI:NewElectricCVCorporationMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member AEI:NewElectricCVCorporationMember 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member AEI:NewElectricCVCorporationMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member AEI:NewElectricCVCorporationMember 2023-12-31 0001750106 AEI:NewElectricCVCorporationMember us-gaap:WarrantMember AEI:MeasurementInputDividendYieldMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 AEI:NewElectricCVCorporationMember us-gaap:WarrantMember AEI:MeasurementInputDividendYieldMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember AEI:VETwoWarrantsMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember AEI:VETwoWarrantsMember 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member AEI:VETwoWarrantsMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member AEI:VETwoWarrantsMember 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member AEI:VETwoWarrantsMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member AEI:VETwoWarrantsMember 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member AEI:VETwoWarrantsMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member AEI:VETwoWarrantsMember 2023-12-31 0001750106 AEI:VETwoWarrantsMember us-gaap:WarrantMember AEI:MeasurementInputDividendYieldMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 AEI:VETwoWarrantsMember us-gaap:WarrantMember AEI:MeasurementInputDividendYieldMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member AEI:VETwoWarrantsMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member AEI:VETwoWarrantsMember 2023-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember AEI:SHRGWarrantsMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member AEI:SHRGWarrantsMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member AEI:SHRGWarrantsMember 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member AEI:SHRGWarrantsMember 2024-03-31 0001750106 AEI:SHRGWarrantsMember us-gaap:WarrantMember AEI:MeasurementInputDividendYieldMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member AEI:SHRGWarrantsMember 2024-03-31 0001750106 AEI:AlsetVillasAgreementMember 2023-11-13 2023-11-13 0001750106 AEI:SectionFourAgreementMember 2023-11-13 2023-11-13 0001750106 AEI:AlsetVillasAgreementMember 2023-11-13 0001750106 2023-11-13 2023-11-13 0001750106 srt:MinimumMember 2024-01-01 2024-03-31 0001750106 srt:MaximumMember 2024-01-01 2024-03-31 0001750106 us-gaap:DepositsMember 2024-03-31 0001750106 us-gaap:DepositsMember 2023-12-31 0001750106 AEI:SGAIMember 2023-01-01 2023-12-31 0001750106 AEI:SGFAndBMember 2023-01-01 2023-12-31 0001750106 AEI:SGFourSeasonsParkMember 2023-01-01 2023-12-31 0001750106 AEI:SGHapiCafeMember 2023-01-01 2023-12-31 0001750106 AEI:SGPLQMember 2023-01-01 2023-12-31 0001750106 AEI:HKOfficeMember 2023-01-01 2023-12-31 0001750106 AEI:HKWarehouseMember 2023-01-01 2023-12-31 0001750106 AEI:HKShopMember 2023-01-01 2023-12-31 0001750106 AEI:HKHapiTravelMember 2023-01-01 2023-12-31 0001750106 AEI:KRHapiCafeMember 2023-01-01 2023-12-31 0001750106 AEI:KRHWHWorldMember 2023-01-01 2023-12-31 0001750106 AEI:BethesdaMarylandMember 2023-01-01 2023-12-31 0001750106 AEI:ChinaCafeMember 2023-01-01 2023-12-31 0001750106 AEI:ChinaOfficeMember 2023-01-01 2023-12-31 0001750106 2022-01-01 2022-12-31 0001750106 AEI:MrChanAndChenMember AEI:HealthWealthHappinessPteLtdMember us-gaap:SubsequentEventMember 2024-04-25 2024-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:SGD utr:acre AEI:Integer utr:sqft iso4217:AUD

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________to _________

 

001-39732

Commission File Number

 

Alset Inc.

(Exact name of registrant as specified in its charter)

 

texas   83-1079861

State or other jurisdiction of

incorporation or organization

 

(I.R.S. Employer

Identification No.)

 

4800 Montgomery Lane, Suite 210,

Bethesda, Maryland

  20814
(Address of principal executive offices)   (Zip Code)

 

301-971-3940

Registrant’s telephone number, including area code

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, $0.001 par value   AEI   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of May 15, 2024, there were 9,235,119 shares of the registrant’s common stock $0.001 par value per share, issued and outstanding.

 

 

 

 
 

 

Table of Contents

 

PART I FINANCIAL INFORMATION F-1
   
Item 1. Financial Statements (Unaudited) F-1
   
Condensed Consolidated Balance Sheets – March 31, 2024 and December 31, 2023 (Unaudited) F-1
   
Condensed Consolidated Statements of Operations and Other Comprehensive Loss - Three Months Ended March 31, 2024 and 2023 (Unaudited) F-2
   
Condensed Consolidated Statements of Stockholders’ Equity – Three Months Ended March 31, 2024 and 2023 (Unaudited) F-3
   
Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2024 and 2023 (Unaudited) F-5
   
Notes to Unaudited Condensed Consolidated Financial Statements F-6 –F-34
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 3
   
Item 3. Quantitative and Qualitative Disclosure About Market Risk 12
   
Item 4. Controls and Procedures 12
   
PART II OTHER INFORMATION 12
   
Item 1. Legal Proceedings 12
   
Item 1A. Risk Factors 12
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 12
   
Item 3. Defaults Upon Senior Securities 12
   
Item 4. Mine Safety Disclosures 12
   
Item 5. Other Information 12
   
Item 6. Exhibits 13
   
SIGNATURES 14

 

2
 

 

Part I. Financial Information

 

Item 1. Financial Statements.

 

Alset Inc. and Subsidiaries

Consolidated Balance Sheets

(Unaudited)

 

   March 31, 2024   December 31, 2023 
Assets:          
Current Assets:          
Cash and Cash Equivalents  $23,727,542   $26,921,727 
Restricted Cash   965,334    967,566 
Account Receivables, Net   85,427    77,517 
Other Receivables, Net   2,835,289    2,576,454 
Note Receivables - Related Parties, Net   1,820,476    1,693,946 
Convertible Loan Receivables at Fair Value - Related Party   939,692    1,207,627 
Prepaid Expense   156,768    253,689 
Advance to Related Party   550,000    - 
Inventory   6,413    5,561 
Investment in Securities at Fair Value   2,982,255    2,148,500 
Investment in Securities at Fair Value - Related Party   7,411,596    11,869,920 
Investment in Securities at Cost   53,601    54,512 
Investment in Equity Method Securities   6,444,660    7,551,153 
Deposits   153,337    133,063 
Total Current Assets   48,132,390    55,461,235 
           
Real Estate          
Rental Properties   31,501,707    31,770,386 
Properties under Development   8,381,922    10,366,766 
Operating Lease Right-Of-Use Assets, Net   1,514,903    1,467,372 
Deposits   429,150    337,606 
Other Receivables - Long Term, Net   6,008,080    4,855,609 
Cash and Marketable Securities Held in Trust Account   -    21,252,639 
Goodwill   60,149    60,343 
Property and Equipment, Net   681,987    742,072 
Total Assets  $96,710,288   $126,314,028 
           
Liabilities and Stockholders’ Equity:          
Current Liabilities:          
Accounts Payable and Accrued Expenses  $3,675,428   $4,372,792 
Deferred Underwriting Compensation   -    3,018,750 
Deferred Revenue   2,100    2,100 
Operating Lease Liabilities   577,836    673,049 
Notes Payable   364,067    30,744 
Notes Payable - Related Parties   16,309    16,869 
Total Current Liabilities   4,635,740    8,114,304 
           
Long-Term Liabilities:          
Operating Lease Liabilities   971,067    826,214 
Notes Payable   1,063,325    126,182 
Total Liabilities   6,670,132    9,066,700 
           
Temporary Equity          
Class A Common Stock of Alset Capital Acquisition Corp subject to possible redemption; 1,976,036 shares at approximately $10.35 per share as of December 31, 2023   -    20,457,011 
           
Stockholders’ Equity:          
Preferred Stock, $0.001 par value; 25,000,000 shares authorized, none issued and outstanding   -    - 
Common Stock, $0.001 par value; 250,000,000 shares authorized; 9,235,119 and 9,235,119 shares issued and outstanding on March 31, 2024 and December 31, 2023, respectively         9,235              9,235    
Additional Paid in Capital   333,711,811    332,455,457 
Accumulated Deficit   (254,655,314)   (247,885,656)
Accumulated Other Comprehensive Income   2,602,960    3,609,719 
Total Alset Inc. Stockholders’ Equity   81,668,692    88,188,755 
Non-controlling Interests   8,371,464    8,601,562 
Total Stockholders’ Equity   90,040,156    96,790,317 
           
Total Liabilities and Stockholders’ Equity  $96,710,288   $126,314,028 

 

See accompanying notes to condensed consolidated financial statements.

 

F-1
 

 

Alset Inc. and Subsidiaries

Consolidated Statements of Operations and Other Comprehensive Loss

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

 

   2024   2023 
         
Revenue          
Rental  $720,494   $633,811 
Property   5,032,500    - 
Biohealth   535    12,786 
Other   332,678    280,339 
Total Revenue   6,086,207    926,936 
Operating Expenses          
Cost of Sales   4,658,367    689,281 
General and Administrative   3,250,854    2,327,385 
Impairment of Goodwill and Investment   443,499    - 
Total Operating Expenses   8,352,720    3,016,666 
           
Loss from Operations   (2,266,513)   (2,089,730)
           
Other Income (Expense)          
Interest Income   220,740    39,278 
Interest Income - Related Party   28,589    - 
Interest Expense   (19,123)   - 
Foreign Exchange Transaction Gain (Loss)   1,193,636    (788,302)
Unrealized Gain (Loss) on Securities Investment   176,634    (2,484,117)
Unrealized (Loss) Gain on Securities Investment - Related Party   (5,442,451)   1,296,271 
Realized Loss on Securities Investment   (152,468)   (131,313)
Loss on Equity Method Investment   (1,121,418)   (268,276)
Other Expense   (1,571)   - 
Other Income   70,153    103,007 
Total Other Income (Expense), Net   (5,047,279)   (2,233,452)
           
Net Loss Before Income Taxes   (7,313,792)   (4,323,182)
           
Income Tax Expense   -    - 
           
Net Loss   (7,313,792)   (4,323,182)
           
Net Loss Attributable to Non-Controlling Interest   (544,134)   (465,296)
           
Net Loss Attributable to Common Stockholders  $(6,769,658)  $(3,857,886)
           
Net Loss  $(7,313,792)  $(4,323,182)
Other Comprehensive Loss          
Foreign Currency Translation Adjustment   (1,161,932)   1,095,943 
Total Comprehensive Loss   (8,475,724)   (3,227,239)
           
Less Comprehensive Loss Attributable to Non-controlling Interests   (713,195)   (305,617)
Total Comprehensive Loss Attributable to Common Shareholders   (7,762,529)   (2,921,622)
           
Net Loss Per Share - Basic and Diluted  $(0.73)  $(0.46)
           
Weighted Average Common Shares Outstanding - Basic and Diluted   9,235,119    8,451,048 

 

See accompanying notes to condensed consolidated financial statements.

 

F-2
 

 

Alset Inc. and Subsidiaries

Consolidated Statements of Stockholders’ Equity

For the Three Months Ended March 31, 2024

(Unaudited)

 

                                                 
   Series A Preferred Stock   Series B Preferred Stock   Common Stock                         
   Shares   Par Value $0.001   Shares   Par Value $0.001   Shares   Par Value $0.001   Additional Paid in Capital   Accumulated Other Comprehensive Income   Accumulated Deficit   Total Alset Stockholders’ Equity   Non-Controlling Interests   Total Stockholders’ Equity 
Balance at January 1, 2024   -   $-    -   $-    9,235,119   $9,235   $332,455,457   $3,609,719   $(247,885,656)  $88,188,755   $8,601,562   $96,790,317 
                                                             
Issuance of HWH Common Stock to EF Hutton for Deferred Underwriting Compensation   -    -    -    -    -    -    1,098,952    -    -    1,098,952    410,423    1,509,375 
                                                             
Gain from SHRG Convertible Note and Warrants   -    -    -    -    -    -    157,402    -    -    157,402    58,786    216,188 
                                                             
Change in Non-Controlling Interest after HWH De SPAC   -    -    -    -    -    -    -    (13,888)   -    (13,888)   13,888    - 
                                                             
Foreign Currency Translations   -    -    -    -    -    -    -    (992,871)   -    (992,871)   (169,061)   (1,161,932)
                                                             
Net Loss   -    -    -    -    -    -    -    -    (6,769,658)   (6,769,658)   (544,134)   (7,313,792)
                                                             
Balance at March 31, 2024   -   $-    -   $-    9,235,119   $9,235   $333,711,811   $2,602,960   $(254,655,314)  $81,668,692   $8,371,464   $90,040,156 

  

F-3
 

 

Alset Inc. and Subsidiaries

Consolidated Statements of Stockholders’ Equity

For the Three Months Ended March 31, 2023

(Unaudited)

 

   Series A Preferred Stock   Series B Preferred Stock   Common Stock                         
   Shares   Par Value $0.001   Shares   Par Value $0.001   Shares   Par Value $0.001   Additional Paid in Capital   Accumulated Other Comprehensive Income   Accumulated Deficit   Total Alset Stockholders’ Equity   Non-Controlling Interests   Total Stockholders’ Equity 
Balance at January 1, 2023   -   $-    -   $-    7,422,846   $7,423   $322,534,891   $3,836,063   $(188,724,411)  $137,653,966   $11,009,149   $148,663,115 
                                                             
Issuance of Common Stock   -    -    -    -    1,812,273    1,812    3,432,109    -    -    3,433,921    -    3,433,921 
                                                             
Foreign Currency Translations   -    -    -    -    -    -    -    936,265    -    936,265    159,678    1,095,943 
                                                             
Net Loss   -    -    -    -    -    -    -    -    (3,857,886)   (3,857,886)   (465,296)   (4,323,182)
                                                             
Balance at March 31, 2023   -   $-    -   $-    9,235,119   $9,235   $325,967,000   $4,772,328   $(192,582,297)  $138,166,266   $10,703,531   $148,869,797 

 

See accompanying notes to condensed consolidated financial statements.

 

F-4
 

 

Alset Inc. and Subsidiaries

Consolidated Statements of Cash Flows

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

 

   2024   2023 
         
Cash Flows from Operating Activities          
Net Loss from Operations  $(7,313,792)  $(4,323,182)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:          
Depreciation   308,695    288,100 
Non-Cash Lease Expenses   307,001    199,193 
Impairment of Goodwill and Investment   443,499    - 
Foreign Transaction (Gain) Loss   (1,193,636)   788,302 
Unrealized (Gain) Loss on Securities Investment   (176,634)   2,484,117 
Unrealized Loss (Gain) on Securities Investment - Related Party   5,442,451    (1,296,271)
Realized Loss on Securities Investment   152,468    131,313 
Loss on Equity Method Investment   1,121,418    268,276 
Changes in Operating Assets and Liabilities, net of acquisitions          
Real Estate   1,984,844    (3,192,223)
Real Estate Reimbursement Receivable   (960,996)   - 
Account Receivables   98,812    108,771 
Prepaid Expense   (20,578)   42,330 
Advances to Related Party   (550,000)   - 
Deposits   (111,609)   - 
Trading Securities   (531,385)   (550,307)
Inventory   (1,620)   555 
Accounts Payable and Accrued Expenses   (210,430)   2,028,362 
Other Receivables - Related Parties   -    (57,500)
Deferred Revenue   -    (21,198)
Operating Lease Liabilities   (297,755)   (187,721)
Net Cash Used in Operating Activities   (1,509,247)   (3,289,083)
           
Cash Flows from Investing Activities          
Purchase of Fixed Assets   (2,072)   (8,277)
Purchase of Investment Securities   (646,785)   (412,500)
Issuing Loan Receivable   (511,234)   - 
Issuing Loan Receivable - Related Party   (633,083)   (1,521,368)
Proceeds from Loan Receivable - Related Party   34,671    2,613,629 
Net Cash (Used in) Provided by Investing Activities   (1,758,503)   671,484 
           
Cash Flows from Financing Activities          
Proceeds from Common Stock Issuance   -    3,433,921 
Borrowing from a Commercial Loan   119,621    - 
Repayment to Notes Payable   (359,803)   - 
Net Cash (Used in) Provided by Financing Activities   (240,182)   3,433,921 
           
Net (Decrease) Increase in Cash and Cash Equivalents and Restricted Cash   (3,507,932)   816,322 
Effects of Foreign Exchange Rates on Cash and Cash Equivalents   311,515    (59,129)
Cash and Cash Equivalents and Restricted Cash - Beginning of Year   27,889,293    18,521,903 
Cash and Cash Equivalents and Restricted Cash- End of Period  $24,692,876   $19,279,096 
           
Cash  $23,727,542   $18,675,450 
Restricted Cash  $965,334   $603,646 
Total Cash and Restricted Cash  $24,692,876   $19,279,096 
           
Supplementary Cash Flow Information          
Cash Paid for Interest  $992   $1,003 
Cash Paid for Taxes  $-   $- 
           
Supplemental Disclosure of Non-Cash Investing and Financing Activities          
Initial Recognition of ROU / Lease Liability  $209,931   $157,647 
Issuance of Shares to EF Hutton to Satisfy Deferred Underwriting Compensation  $1,509,375    - 
Promissory Notes Received in Exchange for Sale of HWH Common Stock to Investors  $16,160,000   $- 
Conversion of Ketomei Note Payable to Common Stock  $310,796   $- 
Gain from SHRG Convertible Notes  $216,188   $- 

 

See accompanying notes to condensed consolidated financial statements.

 

F-5
 

 

Alset Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

 

1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Alset Inc. (the “Company” or “AEI”), formerly known as Alset EHome International Inc. and HF Enterprises Inc., was incorporated in the State of Delaware on March 7, 2018. On October 4, 2022, through a merger transaction, the Company was reincorporated in Texas. AEI is a diversified holding company principally engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities and consumer products with operations in the United States, Singapore, Hong Kong, Australia, South Korea and China. We manage a significant portion of our businesses through our 85.5% owned subsidiary, Alset International Limited (“Alset International”), a public company traded on the Singapore Stock Exchange.

 

The Company has four operating segments based on the products and services we offer, which include three of our principal businesses – real estate, digital transformation technology and biohealth – as well as a fourth category consisting of certain other business activities.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The Company’s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and following the requirements of the Securities and Exchange Commission (“SEC”) for interim reporting. These interim financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or any other interim periods or for any other future years. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Form 10-K for the year ended December 31, 2023 filed on April 1, 2024.

 

The condensed consolidated financial statements include all accounts of the Company and its majority owned and controlled subsidiaries. The Company consolidates entities in which it owns more than 50% of the voting common stock and controls operations. All intercompany transactions and balances among consolidated subsidiaries have been eliminated.

 

F-6
 

 

The Company’s condensed consolidated financial statements include the financial position, results of operations and cash flows of the following entities as of March 31, 2024 and December 31, 2023, as follows:

 

Name of subsidiary 

State or other jurisdiction of incorporation or

  Attributable interest as of, 
consolidated under AEI  organization  March 31, 2024   December 31, 2023 
      %   % 
Alset Global Pte. Ltd.  Singapore   100    100 
Alset Business Development Pte. Ltd.  Singapore   100    100 
Global eHealth Limited  Hong Kong   100    100 
Alset International Limited  Singapore   85.5    85.5 
Singapore Construction & Development Pte. Ltd.  Singapore   85.5    85.5 
Singapore Construction Pte. Ltd.  Singapore   85.5    85.5 
Global BioMedical Pte. Ltd.  Singapore   85.5    85.5 
Health Wealth Happiness Pte. Ltd.  Singapore   73.6    74.6 
SeD Capital Pte. Ltd.  Singapore   85.5    85.5 
LiquidValue Asset Management Pte. Ltd.  Singapore   85.5    85.5 
Alset Solar Limited  Hong Kong   85.5    85.5 
Alset F&B One Pte. Ltd  Singapore   66.2    67.1 
BMI Capital Partners International Limited.  Hong Kong   85.5    85.5 
SeD Perth Pty. Ltd.  Australia   85.5    85.5 
SeD Intelligent Home Inc.  United States of America   85.5    85.5 
LiquidValue Development Inc.  United States of America   85.4    85.4 
Alset EHome Inc.  United States of America   85.4    85.4 
SeD USA, LLC  United States of America   85.4    85.4 
150 Black Oak GP, Inc.  United States of America   85.4    85.4 
SeD Development USA Inc.  United States of America   85.4    85.4 
150 CCM Black Oak, Ltd.  United States of America   85.4    85.4 
SeD Texas Home, LLC  United States of America   100    100 
SeD Ballenger, LLC  United States of America   85.4    85.4 
SeD Maryland Development, LLC  United States of America   71.4    71.4 
SeD Development Management, LLC  United States of America   72.6    72.6 
SeD Builder, LLC  United States of America   85.4    85.4 
Hapi Metaverse Inc.  United States of America   99.6    99.6 
HotApp BlockChain Pte. Ltd.  Singapore   99.6    99.6 
HotApp International Limited  Hong Kong   99.6    99.6 
SeD REIT Inc.  United States of America   85.4    85.4 
HWH World Inc.  United States of America   73.6    74.6 
HWH World Pte. Ltd.  Singapore   73.6    74.6 
UBeauty Limited  Hong Kong   85.5    85.5 
HWH World Limited  Hong Kong   73.6    74.6 
HWH World Inc.  Korea   73.6    74.6 
Alset Energy Inc.  United States of America   85.5    85.5 
NewRetail-AI Inc.  United States of America   99.6    99.6 
BioHealth Water Inc.  United States of America   85.5    85.5 
Impact BioHealth Pte. Ltd.  Singapore   85.5    85.5 
American Home REIT Inc.  United States of America   100    100 
Alset Solar Inc.  United States of America   68.3    68.3 
HWH KOR Inc.  United States of America   73.6    74.6 
Alset Capital Inc.  United States of America   100    100 
Hapi Cafe Inc. (Texas)  United States of America   73.6    74.6 
HWH (S) Pte. Ltd.  Singapore   85.5    85.5 
LiquidValue Development Pte. Ltd.  Singapore   100    100 
LiquidValue Development Limited  Hong Kong   100    100 
Alset F&B Holdings Pte. Ltd.  Singapore   73.6    74.6 
Credas Capital Pte. Ltd.  Singapore   64.1    64.1 
Credas Capital GmbH  Switzerland   64.1    64.1 
Smart Reward Express Limited  Hong Kong   74.1    74.1 
AHR Texas Two LLC  United States of America   100    100 
AHR Black Oak One LLC  United States of America   85.4    85.4 
AHR Texas Three, LLC  United States of America   100    100 
Hapi Cafe Korea, Inc.  Korea   73.6    74.6 
Alset Management Group Inc.  United States of America   83.5    83.5 
Alset Acquisition Sponsor, LLC  United States of America   93.5    93.5 
HWH International Inc. (f.k.a. Alset Capital Acquisition Corp.)  United States of America   73.6    53.7 
Alset Spac Group Inc.  United States of America   93.5    93.5 
Alset eVehicle Pte. Ltd. (f.k.a. Alset Mining Pte. Ltd.)  Singapore   85.5    85.5 
Hapi Travel Pte. Ltd.  Singapore   73.6    74.6 
Hapi WealthBuilder Pte. Ltd.  Singapore   73.6    74.6 
HWH Marketplace Pte. Ltd.  Singapore   73.6    74.6 
HWH International Inc. (Nevada)  United States of America   73.6    74.6 
Hapi Cafe SG Pte. Ltd.  Singapore   73.6    74.6 
Alset Reits Inc.  United States of America   100    100 
Hapi Metaverse Inc. (Texas)  United States of America   99.6    99.6 
Hapi Cafe Limited  Hong Kong   99.6    99.6 
MOC HK Limited  Hong Kong   99.6    99.6 
AHR Texas Four, LLC  United States of America   100    100 
Alset F&B (PLQ) Pte. Ltd.  Singapore   73.6    74.6 
Hapi Cafe Sdn. Bhd.  Malaysia   73.6    74.6 
Shenzhen Leyouyou Catering Management Co., Ltd.  China   99.6    99.6 
Dongguan Leyouyou Catering Management Co., Ltd.  China   99.6    99.6 
Guangzho Leyouyou Catering Management Co., Ltd.  China   99.6    99.6 
Hapi Travel Ltd.  Hong Kong   99.6    99.6 
Hapi Acquisition Pte. Ltd.  Singapore   99.6    99.6 
Robotic Ai Trade Pte. Ltd.  Singapore   85.5    85.5 
Ketomei Pte Ltd  Singapore   41.0*   - 
Hapi MarketPlace Inc.  United States of America   71.2    - 
Hapi Cafe Co., Ltd.  Taiwan   99.6    - 

 

* Although the Company indirectly holds less than 50% of shares of these entities, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.

 

F-7
 

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, but are not limited to, allowance for doubtful accounts, valuation of real estate assets, allocation of development costs and capitalized interest to sold lots, fair value of the investments, the valuation allowance of deferred taxes, and contingencies. Actual results could differ from those estimates.

 

In our property development business, land acquisition costs are allocated to each lot based on the area method, the size of the lot compared to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project.

 

If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot compared to the total size of all lots in the project.

 

When the Company purchases properties but does not receive the assessment information from the county, the Company allocates the values between land and building based on the data of similar properties. The Company makes appropriate adjustments once the assessment from the county is received. At the same time, any necessary adjustments to depreciation expense are made in the income statement. On March 31, 2024 and December 31, 2023, the Company adjusted $0 and $951,349 between building and land, respectively. During the three months ended March 31, 2024 and 2023, the Company adjusted depreciation expenses of $0 and $0, respectively.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less at the date of acquisition to be cash equivalents. Cash and cash equivalents include cash on hand and at the bank and short-term deposits with financial institutions that are readily convertible to a known amount of cash and are subject to an insignificant risk of changes in values. There were no cash equivalents as of March 31, 2024 and December 31, 2023.

 

Restricted Cash

 

As a condition to the loan agreement with the Manufacturers and Traders Trust Company (“M&T Bank”), the Company was required to maintain a minimum of $2,600,000 in an interest-bearing account maintained by the lender as additional security for the loans. The fund was required to remain as collateral for the loan and outstanding letters of credit until the loan and letters of credit are paid off in full and the loan agreement is terminated. The loan has expired during 2022 and only letters of credit were outstanding as of March 31, 2024 and December 31, 2023. On March 15, 2022 approximately $2,300,000 was released from collateral. On December 14, 2023 additional $201,751 was released from collateral. As of March 31, 2024 and December 31, 2023, the total balance of this account was $107,793 and $107,767, respectively.

 

The Company puts money into brokerage accounts specifically for equity investment. As of March 31, 2024 and December 31, 2023, the cash balance in these brokerage accounts was $857,541 and $859,799, respectively.

 

Investments held in Trust Account

 

At March 31, 2024 and December 31, 2023, the Company had approximately $0 and $21.0 million, respectively, in investments in treasury securities held in the Trust Account. The funds in the Trust Account were subject to redemption by investors of HWH International Inc. (formerly known as Alset Capital Acquisition Corp.)

 

F-8
 

 

Account Receivables and Allowance for Credit Losses

 

Account receivables is recorded at invoiced amounts net of an allowance for credit losses and do not bear interest. The allowance for credit losses is the Company’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable. The measurement and recognition of credit losses involves the use of judgment. Management’s assessment of expected credit losses includes consideration of current and expected economic conditions, market and industry factors affecting the Company’s customers (including their financial condition), the aging of account balances, historical credit loss experience, customer concentrations, customer creditworthiness, and the existence of sources of payment The Company also establishes an allowance for credit losses for specific receivables when it is probable that the receivable will not be collected and the loss can be reasonably estimated. Account receivables considered uncollectible are charged against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of March 31, 2024 and December 31, 2023, the allowance for credit losses was an immaterial amount. The Company does not have any off-balance sheet credit exposure related to its customers. As of March 31, 2024 and December 31, 2023, the balance of account receivables was $85,427 and $77,517, respectively.

 

Other Receivables

 

Other receivables include developer reimbursements for Lakes at Black Oak project. The Company records an allowance for credit losses based on previous collection experiences, the creditability of the organizations that are supposed to reimburse us, the forecasts from the third-party engineering company and Moody’s credit ratings. The allowance amount for these reimbursements was immaterial at March 31, 2024 and December 31, 2023.

 

On January 9, 2024, the Company sold 1,600,000 shares of HWH International Inc. (“HWH”) to two investors (800,000 shares to each). The consideration for each of the two purchases of stock is $8,000,000 to be paid through the issuance of a promissory note at the purchase price of $10 per share. These promissory notes carry interest of 1.5% and have maturity dates two years from the date of the notes. Each investor also entered into a Security Agreement. Security interest in the brokerage account into which each investor deposited the Shares (the “Collateral”) shall in each case serve as security for the Company’s repayment of their respective promissory note, and repossession of such Collateral by the Company shall be the sole recourse for non-payment. As of March 31, 2023, the share price of HWH’s stock is $0.95. The Company does not expect that investors will repay the promissory notes when due, as the value of the shares is significantly lower than the original purchase price of $10 per share. The Company expects that all the shares will be returned to the Company at the notes’ maturity date and the notes will be canceled as well. Accordingly, the Company has not recognized the receivable or any gain or loss related to the transaction.

 

Inventories

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method and includes all costs in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs necessary to make the sale. As of March 31, 2024 and December 31, 2023, inventory consisted of finished goods from subsidiaries of HWH International Inc. and Hapi Metaverse Inc. The Company continuously evaluates the need for reserve for obsolescence and possible price concessions required to write-down inventories to net realizable value.

 

Investment Securities

 

Investment Securities at Fair Value

 

The Company records all equity investments with readily determinable fair values at fair value calculated by the publicly traded stock price at the close of the reporting period. Amarantus BioScience Holdings (“AMBS”) and Holista CollTech Limited (“Holista”) are publicly traded companies. The Company does not have significant influence over AMBS and Holista, as the Company holds approximately 4.3% and 13% of the common shares of AMBS and Holista, respectively.

 

On April 12, 2021 the Company acquired 6,500,000 common shares of Value Exchange International, Inc. (“Value Exchange International” or “VEII”), an OTC listed company, for an aggregate subscription price of $650,000. On October 17, 2022 the Company purchased additional 7,276,163 common shares of Value Exchange International for an aggregate purchase price of $1,743,734. On September 6, 2023 the Company converted $1,300,000 of VEII loan into 7,344,632 common shares. After these transactions the Company owns approximately 48.7% of Value Exchange International and exercises significant influence over it. Our Chief Executive Officer, Chan Heng Fai, is also an owner of the common stock of Value Exchange International (not including any common shares we hold). Additionally, certain members of our board of directors serve as directors of Value Exchange International. The stock’s fair value is determined by quoted stock prices.

 

F-9
 

 

On March 20, 2024, HWH International Inc., a subsidiary of the Company (“HWH”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with SHRG, pursuant to which HWH purchased from SHRG a (i) Convertible Promissory Note in the amount of $250,000, convertible into 208,333,333 shares of SHRG’s common stock at the option of HWH, and (ii) certain warrants exercisable into 208,333,333 shares of SHRG’s common stock at an exercise price of $0.0012 per share, the exercise period of the warrant being five (5) years from the date of the Securities Purchase Agreement, for an aggregate purchase price of $250,000. At the time of filing, HWH has not converted any of the debt contemplated by the Convertible Note nor exercised any of the warrants.

 

The Company has a portfolio of trading securities. The objective is to generate profits on short-term differences in market prices. The Company does not have significant influence over any trading securities in our portfolio and fair value of these trading securities are determined by quoted stock prices.

 

The Company has elected the fair value option for the equity securities noted below that would otherwise be accounted for under the equity method of accounting. DSS, Inc. (“DSS”), New Electric CV Corporation (“NECV”), Value Exchange International Inc. and Sharing Services Global Corp. (“SHRG”) are publicly traded companies and fair value is determined by quoted stock prices. The Company has significant influence but does not have a controlling interest in these investments, and therefore, the Company’s investment could be accounted for under the equity method of accounting or elect fair value accounting.

 

  The Company has significant influence over DSS. As of March 31, 2024 and December, 2023, the Company owned approximately 44.4% and 44.4% of the common stock of DSS, respectively. Our CEO is a stockholder and the Chairman of the Board of Directors of DSS. Chan Tung Moe, our Co-Chief Executive Officer and the son of Chan Heng Fai, is also a director of DSS. William Wu, Wong Shui Yeung and Joanne Wong Hiu Pan, directors of the Company, are each also directors of DSS.
     
  The Company has significant influence over NECV as the Company holds approximately 0.5% of the common shares of NECV and one employee from the Company holds a director position on NECV’s Board of Directors.
     
  The Company has significant influence over Value Exchange International as the Company holds approximately 48.7% of the common shares of VEII. Mr. Chan and another member of the Board of Directors of Hapi Metaverse Inc., Lum Kan Fai Vincent, are both members of the Board of Directors of VEII. In addition to Mr. Chan, two other members of the Board of Directors of Alset Inc. are also members of the Board of Directors of VEII (Wong Shui Yeung and Wong Tat Keung).
     
  The Company has significant influence over SHRG as the Company holds approximately 33.4% of the common shares of SHRG and our CEO holds a director position on SHRG’s Board of Directors. Additionally, our CEO is a significant stockholder of SHRG shares.

 

On August 8, 2023, DSS Inc. distributed shares of Impact Biomedical Inc. (“Impact”), beneficially held by DSS, in the form of a dividend to the shareholders of DSS common stock. As a result of this distribution, the Company and its majority owned subsidiaries received 4,568,165 shares of Impact, representing 6.5% of the issued and outstanding shares of Impact Common Stock. Each share of Impact distributed as part of the distribution is not eligible for resale until 180 days from the date Impact’s initial public offering becomes effective under the Securities Act, subject to the discretion of DSS to lift the restriction sooner. As of March 31, 2024 and December 31, 2023, Impact was a startup private company. Based on the management’s analysis, the fair value of Impact shares was approximately $0 at the distribution date and as of March 31, 2024 and December 31, 2023.

 

F-10
 

 

Investment Securities at Cost

 

Investments in equity securities without readily determinable fair values are measured at cost minus impairment adjusted by observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These investments are measured at fair value on a nonrecurring basis when there are events or changes in circumstances that may have a significant adverse effect. An impairment loss is recognized in the consolidated statements of comprehensive income equal to the amount by which the carrying value exceeds the fair value of the investment.

 

On September 8, 2020, the Company acquired 1,666 shares, approximately 1.45% ownership, from Nervotec Pte Ltd (“Nervotec”), a private company, at the purchase price of $37,826. The Company applied ASC 321 and measured Nervotec at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer.

 

On September 30, 2020, the Company acquired 3,800 shares, approximately 19% ownership, from HWH World Company Limited (f.k.a. Hyten Global (Thailand) Co., Ltd.) (“HWH World Co.”), a private company, at a purchase price of $42,562. The Company’s subsidiary holding equity in HWH World Co. was sold on December 31, 2023.

 

During 2021, the Company invested $19,609 in K Beauty Research Lab Co., Ltd (“K Beauty”) for 18% ownership. K Beauty was established for sourcing, developing and producing variety of Korea-made beauty products as well as Korea - originated beauty contents for the purpose of distribution to HWH’s membership distribution channel.

 

There has been no indication of impairment or changes in observable prices via transactions of similar securities and investments are still carried at cost.

 

Equity Method Investment

 

The Company accounts for equity investment in entities with significant influence under equity-method accounting. Under this method, the Group’s pro rata share of income (loss) from investment is recognized in the condensed consolidated statements of comprehensive income. Dividends received reduce the carrying amount of the investment. When the Company’s share of loss in an equity-method investee equals or exceeds its carrying value of the investment in that entity, the equity method investment can be reduced below zero based on losses, if the Company either is liable for the obligations of the investee or provides for losses in excess of the investment when imminent return to profitable operations by the investee appears to be assured. Otherwise, the Company does not recognize its share of equity method losses exceeding its carrying amount of the investment, but discloses the losses in the footnotes. Equity-method investment is reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other-than-temporary. In making this determination, factors are evaluated in determining whether a loss in value should be recognized. These include consideration of the intent and ability of the Group to hold investment and the ability of the investee to sustain an earnings capacity, justifying the carrying amount of the investment. Impairment losses are recognized in other expense when a decline in value is deemed to be other-than-temporary.

 

American Medical REIT Inc.

 

LiquidValue Asset Management Pte. Ltd. (“LiquidValue”), a subsidiary of the Company, owns 15.8% of American Medical REIT Inc. (“AMRE”) as of March 31, 2024, a company concentrating on medical real estate. AMRE acquires state-of-the-art, purpose-built healthcare facilities and leases them to leading clinical operators with dominant market share under secure triple net leases. AMRE targets hospitals (both Critical Access and Specialty Surgical), Physician Group Practices, Ambulatory Surgical Centers, and other licensed medical treatment facilities. Chan Heng Fai, our Chairman and CEO, is the executive chairman and director of AMRE. DSS, of which we own 44.4% and have significant influence over, owns 80.8% of AMRE. Therefore, the Company has significant influence on AMRE.

 

American Pacific Financial, Inc.

 

Pursuant to Securities Purchase Agreement from March 12, 2021 the Company purchased 4,775,523 shares of the common stock of American Pacific Financial, Inc., formerly known as American Pacific Bancorp, Inc. (“APF”) and gained majority ownership in that entity. APF was consolidated into the Company under common control accounting. On September 8, 2021 APF sold 6,666,700 shares Series A Common Stock to DSS, Inc. for $40,000,200 cash. As a result of the new share issuances, the Company’s ownership percentage of APF fell below 50% to 41.3% (and subsequently to 36.9%) and the entity was deconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method accounting as the Company still retained significant influence over APF. During the three months ended March 31, 2024 and 2023, the investment loss was $1,079,937 and $17,749, respectively. As of March 31, 2024 and December 31, 2023, the investment in APF was $6,346,453 and $7,426,390, respectively.

 

F-11
 

 

Ketomei Pte Ltd

 

On June 10, 2021 the Company’s indirect subsidiary Hapi Café Inc. (“HCI-T” or “Hapi Café”) lent $76,723 to Ketomei Pte. Ltd. (“Ketomei”). On March 21, 2022 HCI-T entered into an agreement pursuant to which the principal of the loan together with accrued interest were converted into an investment in Ketomei. At the same time, Hapi Cafe invested an additional $179,595 in Ketomei. After the conversion and fund investment HCI-T held 28% of Ketomei as of December 31, 2023. Ketomei is in the business of selling cooked food and drinks. At December 31, 2023, the Company wrote off the investment in Ketomei of $121,471, as the Company does not believe it will be able to recover this investment. On February 20, 2024, Hapi Cafe invested $312,064 for an additional 38.41% ownership interest in Ketomei by converting $312,064 of convertible loan. The loan was impaired at the year ended of December 31, 2023, therefore, $312,064 was transferred from impairment of convertible loan to impairment of equity method investment. After this additional investment, Hapi Cafe owns 55.65% (the Company owns indirectly 41%) of Ketomei’s outstanding shares and Ketomei is consolidated into the financial statements of the Company beginning on February 20, 2024.

 

Sentinel Brokers Company Inc.

 

On May 22, 2023 the Company’s indirect subsidiary, SeD Capital Pte Ltd (“SeD Capital”), entered into a Stock Purchase Agreement, pursuant to which SeD Capital purchased 39.8 shares (11.6%) of the Common Stock of Sentinel Brokers Company Inc. (“Sentinel”) for the aggregate purchase price of $279,719. Sentinel is a broker-dealer operating primarily as a fiduciary intermediary, facilitating institutional trading of municipal and corporate bonds as well as preferred stock, and is registered with the Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”), and is a member of the Securities Investor Protection Corporation (“SIPC”). The Company has significant influence over Sentinel as its CEO holds a director position on Sentinel’s Board of Directors. Additionally, DSS, of which we own 44.4% and have significant influence over, owns 80.1% of Sentinel. During the three months ended March 31, 2024 and 2023 the investment loss in Sentinel was $26,737 and $0, respectively. Investment in Sentinel was $98,027 and $124,763 at March 31, 2024 and December 31, 2023, respectively.

 

Investment in Debt Securities

 

Debt securities are reported at fair value, with unrealized gains and losses (other than impairment losses) recognized in accumulated other comprehensive income or loss. Realized gains and losses on debt securities are recognized in the net income in the consolidated statements of comprehensive income. The Company monitors its investments for other-than-temporary impairment by considering factors including, but not limited to, current economic and market conditions, the operating performance of the companies including current earnings trends and other company-specific information.

 

On February 26, 2021, the Company invested approximately $88,599 in the convertible note of Vector Com Co., Ltd (“Vector Com”), a private company in South Korea. The interest rate is 2% per annum. The conversion price is approximately $21.26 per common share of Vector Com. As of December 31, 2023, the Management estimated the fair value of the note to be $88,599. The Company wrote off this loan at March 31, 2024.

 

Variable Interest Entity

 

Under Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 810, Consolidation, when a reporting entity is the primary beneficiary of an entity that is a variable interest entity (“VIE”), as defined in ASC 810, the VIE must be consolidated into the financial statements of the reporting entity. The determination of which owner is the primary beneficiary of a VIE requires management to make significant estimates and judgments about the rights, obligations, and economic interests of each interest holder in the VIE.

 

The Company evaluates its interests in VIEs on an ongoing basis and consolidates any VIE in which it has a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be significant to the VIE.

 

Real Estate Assets

 

Real estate assets are recorded at cost, except when real estate assets are acquired that meet the definition of a business combination in accordance with FASB ASC 805 - “Business Combinations”, which acquired assets are recorded at fair value. Interest, property taxes, insurance and other incremental costs (including salaries) directly related to a project are capitalized during the construction period of major facilities and land improvements. The capitalization period begins when activities to develop the parcel commence and ends when the asset constructed is completed. The capitalized costs are recorded as part of the asset to which they relate and are reduced when lots are sold.

 

F-12
 

 

The Company capitalized construction costs of approximately $3 million and $2.5 million for the three months ended March 31, 2024 and 2023, respectively.

 

The Company’s policy is to obtain an independent third-party valuation for each major project in the United States as part of our assessment of identifying potential triggering events for impairment. Management may use the market comparison method to value other relatively small projects. In addition to the annual assessment of potential triggering events in accordance with ASC 360 – Property Plant and Equipment (“ASC 360”), the Company applies a fair value-based impairment test to the net book value assets on an annual basis and on an interim basis if certain events or circumstances indicate that an impairment loss may have occurred.

 

The Company did not record impairment on any of its projects during the three months ended on March 31, 2024 and 2023.

 

Properties under development

 

Properties under development are properties being constructed for sale in the ordinary course of business, rather than to be held for the Company’s own use, rental or capital appreciation.

 

Rental Properties

 

Rental properties are acquired with the intent to be rented to tenants. As of March 31, 2024 and December 31, 2023, the Company owned 132 homes. The aggregate purchase cost of all the homes is $30,998,258. These homes are located in Montgomery and Harris Counties, Texas. All of these purchased homes are properties of our rental business.

 

Investments in Single-Family Residential Properties

 

The Company accounts for its investments in single-family residential properties as asset acquisitions and records these acquisitions at their purchase price. The purchase price is allocated between land, building and improvements based upon their relative fair values at the date of acquisition. The purchase price for purposes of this allocation is inclusive of acquisition costs which typically include legal fees, title fees, property inspection and valuation fees, as well as other closing costs.

 

Building improvements and buildings are depreciated over estimated useful lives of approximately 10 to 27.5 years, respectively, using the straight-line method.

 

The Company assesses its investments in single-family residential properties for impairment whenever events or changes in business circumstances indicate that carrying amounts of the assets may not be fully recoverable. When such events occur, management determines whether there has been impairment by comparing the asset’s carrying value with its fair value. Should impairment exist, the asset is written down to its estimated fair value. The Company did not recognize any impairment losses during three months ended March 31, 2024 and 2023.

 

Rental of Model Houses

 

In May 2023, the Company entered into lease agreement for one of its model houses located in Montgomery County, Texas.

 

On July 14, 2023, 150 CCM Black Oak Ltd entered into a model home lease agreement with Davidson Homes, LLC (“Davidson”). On August 3, 2023, 150 CCM Black Oak Ltd entered into a development and construction agreement with Davidson Homes, LLC to build a model house located in Montgomery County, Texas. On January 4, 2024, 150 CCM Black Oak Ltd sent $220,076 to Davidson as reimbursement for final construction cost and the contractor’s fee. The model home lease commenced on January 1, 2024, lease term is twenty-four (24) full months and annual base rent equals to twelve percentage (12%) of the total of the final cost of construction costs and the contractor’s fee.

 

Revenue Recognition and Cost of Revenue

 

ASC 606 - Revenue from Contracts with Customers (“ASC 606”), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers.

 

F-13
 

 

In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which the determination of revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which the Company expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps:

 

(1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, performance obligations are satisfied.

 

The following represents the Company’s revenue recognition policies by Segments:

 

Real Estate

 

Property Sales

 

Part of the Company’s real estate business is land development. The Company purchases land and develops it for building into residential communities. The developed lots are sold to builders (customers) for the construction of new homes. The builders enter a sales contract with the Company before they take the lots. The prices and timeline are determined and agreed upon in the contract. The builders do the inspections to make sure all conditions and requirements in contracts are met before purchasing the lots. A detailed breakdown of the five-step process for the revenue recognition of the Lakes at Black Oak project, which represented approximately 83% and 0% of the Company’s revenue in the three months ended March 31, 2024 and 2023, is as follows:

 

  Identify the contract with a customer.

 

The Company has signed agreements with the builders for developing the raw land to ready to build lots. The contract has agreed upon prices, timelines, and specifications for what is to be provided.

 

  Identify the performance obligations in the contract.

 

Performance obligations of the Company include delivering developed lots to the customer, which are required to meet certain specifications that are outlined in the contract. The customer inspects all lots prior to accepting title to ensure all specifications are met.

 

  Determine the transaction price.

 

The transaction price per lot is fixed and specified in the contract. Any subsequent change orders or price changes are required to be approved by both parties.

 

  Allocate the transaction price to performance obligations in the contract.

 

Each lot or a group of lots is considered to be a separate performance obligation, for which the specified price in the contract is allocated to.

 

  Recognize revenue when (or as) the entity satisfies a performance obligation.

 

The builders do the inspections to make sure all conditions/requirements are met before taking title of lots. The Company recognizes revenue at a point in time when title is transferred. The Company does not have further performance obligations or continuing involvement once title is transferred. Revenue is recognized at a point in time.

 

F-14
 

 

Rental Revenue

 

The Company leases real estate properties to its tenants under leases that are predominately classified as operating leases, in accordance with ASC 842, Leases (“ASC 842”). Real estate rental revenue is comprised of minimum base rent and revenue from the collection of lease termination fees.

 

Rent from tenants is recorded in accordance with the terms of each lease agreement on a straight-line basis over the initial term of the lease. Rental revenue recognition begins when the tenant controls the space and continues through the term of the related lease. Generally, at the end of the lease term, the Company provides the tenant with a one-year renewal option, including mostly the same terms and conditions provided under the initial lease term, subject to rent increases.

 

The Company defers rental revenue related to lease payments received from tenants in advance of their due dates. These amounts are presented within deferred revenues and other payables on the Company’s consolidated balance sheets.

 

Rental revenue is subject to an evaluation for collectability on several factors, including payment history, the financial strength of the tenant and any guarantors, historical operations and operating trends of the property, and current economic conditions. If our evaluation of these factors indicates that it is not probable that we will recover substantially all of the receivable, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis (as applicable) or the lease payments that have been collected from the lessee. Differences between rental revenue recognized and amounts contractually due under the lease agreements are credited or charged to straight-line rent receivable or straight-line rent liability, as applicable. In the three months ended March 31, 2024 and the year ended December 31, 2023, the Company did not recognize any deferred revenue and collected all rents due.

 

Cost of Revenues

 

Real Estate

 

  Cost of Real Estate Sale

 

All of the costs of real estate sales are from our land development business. Land acquisition costs are allocated to each lot based on the area method, the size of the lot comparing to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project.

 

If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot comparing to the total size of all lots in the project.

 

  Cost of Rental Revenue

 

Cost of rental revenue consists primarily of the costs associated with management and leasing fees to our management company, repairs and maintenance, depreciation and other related administrative costs. Utility expenses are paid directly by tenants.

 

F-15
 

 

Biohealth

 

  Product Direct Sales

 

The Company’s net sales consist of product sales. The Company’s performance obligation is to transfer ownership of its products to its members. The Company generally recognizes revenue when product is delivered to its members. Revenue is recorded net of applicable taxes, allowances, refund or returns. The Company receives the net sales price in cash or through credit card payments at the point of sale.

 

If any member returns a product to the Company on a timely basis, they may obtain a replacement product from the Company for such returned products. We do not have buyback program. However, when the customer requests a return and management decides that the refund is necessary, we initiate the refund after deducting all the benefits that a member has earned. The returns are deducted from our sales revenue on our financial statements. Allowances for product and membership returns are provided at the time the sale is recorded. This accrual is based upon historical return rates for each country and the relevant return pattern, which reflects anticipated returns to be received over a period of up to 12 months following the original sale. Product and membership returns for the three months ended March 31, 2024 and 2023 were approximately $0 and $1,162, respectively.

 

  Annual Membership

 

The Company collects an annual membership fee from its members. The fee is fixed, paid in full at the time upon joining the membership; the fee is not refundable. The Company’s performance obligation is to provide its members the right to (a) purchase products from the Company, (b) access to certain back-office services, (c) receive commissions and (d) attend corporate events. The associated performance obligation is satisfied over time, generally over the term of the membership agreement which is for a one-year period. Before the membership fee is recognized as revenue, it is recorded as deferred revenue. Deferred revenue relating to membership was $0 and $0 at March 31, 2024 and December 31, 2023, respectively. Starting in 2020 the revenue from sale of membership declined to $0 in 2022. The Company is currently working on a new membership model.

 

Other Businesses

 

  Food and Beverage

 

The Company, through Alset F&B One and Alset F&B PLQ each acquired a restaurant franchise licenses at the end of 2021 and 2022 respectively, both of which have since commenced operations. These licenses will allow Alset F&B One and Alset F&B PLQ each to operate a Killiney Kopitiam restaurant in Singapore. Killiney Kopitiam, founded in 1919, is a Singapore-based chain of mass-market, traditional kopitiam style service cafes selling traditional coffee and tea, along with a range of local delicacies such as Curry Chicken, Laksa, Mee Siam, and Mee Rebus.

 

The Company, through HCI-T, commenced operation of two cafés during 2022 and 2021, which are located in Singapore and South Korea.

 

The cafes are operated by subsidiaries of HCI-T, namely HCSG in Singapore and HCKI in Seoul, South Korea. Hapi Cafes are distinctive lifestyle café outlets that strive to revolutionize the way individuals dine, work, and live, by providing a conducive environment for everyone to relish the four facets – health and wellness, fitness, productivity, and recreation all under one roof.

 

In 2023 the Company incorporated three new subsidiaries Shenzhen Leyouyou Catering Management Co., Ltd., Dongguan Leyouyou Catering Management Co., Ltd. and GuangZhou Leyouyou Catering Management Co., Ltd in the People’s Republic of China. The three companies are principally engaged in the food and beverage business in Mainland China.

 

Additionally, through its subsidiary MOC HK Limited, the Company is focusing on operating café business in Hong Kong.

 

  Remaining performance obligations

 

As of March 31, 2024 and December 31, 2023, there were no remaining performance obligations or continuing involvement, as all service obligations within the other business activities segment have been completed.

 

F-16
 

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. During the three months ended on March 31, 2024 and 2023, the Company recorded $0 as stock-based compensation expense.

 

Foreign currency

 

Functional and reporting currency

 

Items included in the financial statements of each entity in the Company are measured using the currency of the primary economic environment in which the entity operates (“functional currency”). The financial statements of the Company are presented in U.S. dollars (the “reporting currency”).

 

The functional and reporting currency of the Company is the United States dollar (“U.S. dollar”). The financial records of the Company’s subsidiaries located in Singapore, Hong Kong, Australia, South Korea and the People’s Republic of China are maintained in their local currencies, the Singapore Dollar (S$), Hong Kong Dollar (HK$), Australian Dollar (“AUD”), South Korean Won (“KRW”) and Chinese Yuan (CN¥), which are also the functional currencies of these entities.

 

Transactions in foreign currencies

 

Transactions in currencies other than the functional currency during the periods are converted into functional currency at the applicable rates of exchange prevailing when the transactions occurred. Transaction gains and losses are recognized in the statement of operations.

 

The majority of the Company’s foreign currency transaction gains or losses come from the effects of foreign exchange rate changes on the intercompany loans between Singapore entities and U.S. entities. The Company recorded foreign exchange gain of $1,193,636 and $788,302 loss during the three months ended on March 31, 2024 and 2023, respectively. The foreign currency transactional gains and losses are recorded in operations.

 

Translation of consolidated entities’ financial statements

 

Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at the rates of exchange ruling at the balance sheet date. The Company’s entities with functional currency of S$, HK$, AUD, KRW and CN¥, translate their operating results and financial positions into the U.S. dollar, the Company’s reporting currency. Assets and liabilities are translated using the exchange rates in effect on the balance sheet date. Revenue, expense, gains and losses are translated using the average rate for the year. Translation adjustments are reported as cumulative translation adjustments and are shown as a separate component of comprehensive income (loss).

 

The Company recorded other comprehensive loss of $1,161,932 from foreign currency translation for the three months ended March 31, 2024 and $1,095,943 gain for the three months ended March 31, 2023, in accumulated other comprehensive loss.

 

Earnings (loss) per Share

 

The Company presents basic and diluted earnings (loss) per share data for its common shares. Basic earnings (loss) per share is calculated by dividing the profit or loss attributable to common stock shareholders of the Company by the weighted-average number of common shares outstanding during the year, adjusted for treasury shares held by the Company.

 

Diluted earnings (loss) per share is determined by adjusting the profit or loss attributable to common stock shareholders and the weighted-average number of common shares outstanding, adjusted for treasury shares held, for the effects of all dilutive potential ordinary shares, which comprise convertible securities, such as stock options, convertible bonds and warrants. At March 31, 2024 there were 425,216 potentially dilutive warrants outstanding. At December 31, 2023 there were 425,216 potentially dilutive warrants outstanding.

 

F-17
 

 

Fair Value Measurements

 

ASC 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

 

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

 

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

 

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

 

The carrying value of the Company’s financial instruments, including cash and restricted cash, accounts receivable and accounts payable and accrued expenses approximate fair value because of the short-term maturity of these financial instruments. The liabilities in connection with the conversion and make-whole features included within certain of the Company’s notes payable and warrants are each classified as a level 3 liability.

 

Non-controlling interests

 

Non-controlling interests represent the equity in subsidiary not attributable, directly or indirectly, to owners of the Company, and are presented separately in the condensed consolidated statements of operation and comprehensive income, and within equity in the Condensed Consolidated Balance Sheets, separately from equity attributable to owners of the Company.

 

On March 31, 2024 and December 31, 2023, the aggregate non-controlling interests in the Company were $8,371,464 and $8,601,562, respectively.

 

Capitalized Financing Costs

 

Financing costs, such as loan origination fee, administration fee, interests, and other related financing costs should be capitalized and recorded on the balance sheet, if these financing activities are directly associated with the development of real estate.

 

Capitalized financing costs are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If the allocation of capitalized financing costs based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on an area method, which uses the size of the lots compared to the total project area and allocates costs based on their size.

 

As of March 31, 2024 and December 31, 2023, the capitalized financing costs were $756,942 and $1,225,739, respectively.

 

3. CONCENTRATIONS

 

The Company maintains cash balances at various financial institutions in different countries. These balances are usually secured by the central banks’ insurance companies. At times, these balances may exceed the insurance limits. As of March 31, 2024 and December 31, 2023, uninsured cash and restricted cash balances were $20,945,321 and $23,748,169, respectively.

 

For the three months ended March 31, 2024, one customer accounted for approximately 100% of the Company’s property development revenue.

 

4. SEGMENTS

 

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: real estate, digital transformation technology, biohealth, and other business activities. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.

 

F-18
 

 

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the three months ended March 31, 2024 and 2023:

 

   Real Estate   Digital Transformation Technology   Biohealth Business   Other   Total 
                     
Three Months Ended on March 31, 2024                         
Revenue  $5,752,994   $-   $535   $332,678   $6,086,207 
Cost of Sales   (4,533,660)   -    (2,041)   (122,666)   (4,658,367)
Gross Margin   1,219,334    -    (1,506)   210,012    1,427,840 
Operating Expenses   (361,696)   (163,707)   (826,961)   (2,341,990)   (3,694,354)
Operating Income (Loss)   857,638    (163,707)   (828,497)   (2,131,977)   (2,266,513)
Other Income (Expense)   15,148    (3,491,466)   (205,821)   1,365,140    (5,047,279)
Net Income (Loss) Before Income Tax   872,786    (3,655,173)   (1,034,288)   (3,497,117)   (7,313,792)

 

   Real Estate   Digital Transformation Technology   Biohealth Business   Other   Total 
                     
Three Months Ended on March 31, 2023                         
Revenue  $633,811   $14,040   $12,786   $266,299   $926,936 
Cost of Sales   (602,340)   (4,568)   (14,367)   (68,006)   (689,281)
Gross Margin   31,471    9,472    (1,581)   198,293    237,655 
Operating Expenses   (440,017)   (139,903)   (141,290)   (1,606,175)  $(2,327,385)
Operating Loss   (408,546)   (130,431)   (142,871)   (1,407,882)   (2,089,730)
Other Income (Expense)   45    (1,061,068)   319,635    (1,492,064)  $(2,233,452)
Net Loss Before Income Tax   (408,501)   (1,191,499)   176,764    (2,899,946)   (4,323,182)
                          
March 31, 2024                         
Cash and Restricted Cash  $2,988,864   $312,996   $411,751   $20,979,265   $24,692,876 
Total Assets   63,338,168    2,340,946    2,077,355    28,953,819    96,710,288 
                          
December 31, 2023                         
Cash and Restricted Cash  $3,323,210   $430,807   $568,702   $23,566,574   $27,889,293 
Total Assets   62,989,233    5,845,269    2,450,876    55,028,650    126,314,028 

 

5. REAL ESTATE ASSETS

 

As of March 31, 2024 and December 31, 2023, real estate assets consisted of the following:

 

   March 31,
2024
   December 31,
2023
 
         
Construction in Progress  $6,053,443   $6,983,974 
Land Held for Development   2,328,479    3,382,792 
Rental Properties, net   31,501,707    31,770,386 
Total Real Estate Assets  $39,883,629   $42,137,152 

 

F-19
 

 

Single family residential properties

 

As of March 31, 2024 and December 31, 2023, the Company owned 132 Single Family Residential Properties (“SFRs”). The Company’s aggregate investment in those SFRs was $31 million. Depreciation expense was $264,052 and $243,702 in the three months ended March 31, 2024 and 2023, respectively. These homes are located in Montgomery and Harris Counties, Texas.

 

The following table presents the summary of our SFRs as of March 31, 2024:

 

  

Number of

Homes

  

Aggregate

investment

  

Average Investment

per Home

 
SFRs   132   $33,190,603   $251,444 

 

6. NOTES PAYABLE

 

As of March 31, 2024 and December 31, 2023, notes payable consisted of the following:

 

  

March 31,

2024

  

December 31,

2023

 
Motor Vehicle Loans  $145,784   $156,926 
Loans for Operations   97,233    - 
Promissory Note to EF Hutton   1,184,375    - 
Total notes payable  $1,427,392   $156,926 

 

M&T Bank Loan

 

On April 17, 2019, SeD Maryland Development LLC entered into a Development Loan Agreement with Manufacturers and Traders Trust Company (“M&T Bank”) in the principal amount not to exceed at any one time outstanding the sum of $8,000,000, with a cumulative loan advance amount of $18,500,000. The line of credit bore interest rate on LIBOR plus 375 basis points. SeD Maryland Development LLC was also provided with a Letter of Credit (“L/C”) Facility in an aggregate amount of up to $900,000. The L/C commission will be 1.5% per annum on the face amount of the L/C. Other standard lender fees will apply in the event L/C is drawn down. The loan is a revolving line of credit. The L/C Facility is not a revolving loan, and amounts advanced and repaid may not be re-borrowed. Repayment of the Loan Agreement is secured by $2,600,000 collateral fund and a Deed of Trust issued to the Lender on the property owned by SeD Maryland. The loan has expired during 2022 and only L/C is outstanding as of March 31, 2024 and December 31, 2023. On March 15, 2022 approximately $2,300,000 was released from collateral, leaving approximately $300,000 as collateral for outstanding letters of credit. On December 14, 2023 approximately $201,751 was released from collateral, leaving approximately $100,000 as collateral for outstanding letters of credit.

 

Motor Vehicle Loans

 

On May 17, 2021, Alset International entered into an agreement with Hong Leong Finance Limited to purchase a car for business. The total purchase price of the car, including associated charges, was approximately $184,596. Alset International paid an initial deposit of $78,640, and would make monthly instalment of approximately $1,300, including interest of 1.88% per annum, for the 84 months.

 

On September 22, 2022 Alset International entered into an agreement with United Overseas Bank Limited to purchase additional car for business. The total purchase price of the car, including associated charges, was approximately $182,430. Alset International paid an initial deposit of $66,020 and would make monthly installments of approximately $1,472, including interest of 1.88% per annum, for the 84 months.

 

F-20
 

 

Future minimum principal payments under existing motor vehicle loans at March 31, 2024 in each calendar year through the end of their terms are as follows:

 

      
2025   30,032 
2026   30,032 
2027   30,032 
2028   30,032 
Thereafter   25,656 
Total Future Receipts  $145,784 

 

Loans for Operations

 

Company’s subsidiary, Ketomei Pte Ltd (“Ketomei”) has a loan from DBS Bank Limited, which was used to fund Ketomei’s current operations. Ketomei owns the bank $54,313 at March 31, 2024.

 

Ketomei borrowed also funds from an individual to whom Ketomei owns $42,919 at March 31, 2024.

 

Promissory Note to EF Hutton

 

On December 18, 2023, the Company’s subsidiary, HWH International Inc. (“HWH”) entered into a Satisfaction and Discharge of Indebtedness Agreement in connection with an underwriting agreement previously entered into by HWH and EF Hutton, a division of Benchmark Investments, LLC, under which in lieu of HWH tendering the full amount due of $3,018,750, the underwriters accepted a combination of $325,000 in cash upon the closing of the business combination, 149,443 shares of the Company’s common stock and a $1,184,375 promissory note as full satisfaction. This agreement was effective at the closing of business combination on January 9, 2024. The 149,443 shares were issued as of the price of $10.10, totaling the amount of $1,509,375. The fair value of the HWH shares at issuance on January 9, 2024 was $2.82 per share or $421,429. No gain or loss was recognized upon issuance of the shares on January 9, 2024 as this was an adjustment to prior underwriting costs accounted for in equity. The promissory note carries interest rate equal to SOFR (secured overnight financing rate for U.S. Government Securities Business Day published by the Federal Reserve Bank of New York) plus a margin of one percent. The principal amount of the promissory note and any accrued interest shall mature (i) partially in the event HWH completes an offering within one year of the date of the promissory note, the amount of outstanding debt maturing being proportionate to the amount of proceeds of the future offering, or (ii) in partial installments through October of 2028, the outstanding balance being paid annually until the balance owed is paid in full.

 

7. RELATED PARTY TRANSACTIONS

 

Purchase of Shares and Warrants from NECV

 

On July 17, 2020, the Company purchased 122,039,000 shares, approximately 9.99% ownership, and warrants to purchase 1,220,390,000 shares with an exercise price of $0.0001 per share, from NECV, for an aggregate purchase price of $122,039. We value the NECV warrants under level 3 category through a Black Scholes option pricing model and the fair value of the NECV warrants were $860,342 as of July 17, 2020, the purchase date, $973 as of March 31, 2024 and $430 as of December 31, 2023. The difference of $945,769 of fair value of stock and warrants, total $1,067,808 and the purchase price $122,039, was recorded as additional paid in capital at December 31, 2021, as it was a related party transaction.

 

Reorganization of Home Rental Business

 

On December 9, 2022, the Company entered into an agreement with Alset EHome Inc. and Alset International, two majority-owned subsidiaries of the Company, pursuant to which the Company agreed to reorganize the ownership of its home rental business. Previously, the Company and certain majority-owned subsidiaries collectively owned 132 single-family rental homes in Texas. 112 of these rental homes are owned by subsidiaries of American Home REIT Inc. (“AHR”). The Company owns 85.5% of Alset International, and Alset International indirectly owns approximately 99.9% of Alset EHome Inc.

 

The closing of the transaction contemplated by this agreement was completed on January 13, 2023. Pursuant to this agreement, the Company became the direct owner of AHR and its subsidiaries that collectively own these 112 homes, instead of such homes being owned indirectly through Alset International’s subsidiaries.

 

Alset EHome Inc. sold AHR to the Company for a total consideration of $26,250,933, including the forgiveness of debt in the amount of $13,900,000, a promissory note in the amount of $11,350,933 and a cash payment of $1,000,000. This purchase price represents the book value of AHR as of November 30, 2022. The promissory note carries interest rate of 7.2% and matures on January 13, 2028.

 

F-21
 

 

The closing of the transaction was approved by the shareholders of Alset International. Certain members of the Company’s Board of Directors and management are also members of the Board of Directors and management of each of Alset International and Alset EHome Inc.

 

SHRG Shares Dividend Received from DSS

 

On May 4, 2023, DSS distributed approximately 280 million shares of Sharing Services Global Corporation (“SHRG”) beneficially held by DSS and its subsidiaries in the form of a dividend to the shareholders of DSS common stock. As a result of this distribution, the Company directly received 70,426,832 shares of SHRG, and through its majority-owned subsidiary Alset International, and certain subsidiaries of Alset International, indirectly received additional 55,197,696 shares of SHRG. The Company and its majority-owned subsidiaries now collectively own 125,624,528 shares of SHRG, representing 33.4% of the issued and outstanding shares of SHRG Common Stock (such number of SHRG shares held and ownership percentage do not include any shares held by affiliates of the Company which we do not hold a majority interest in). Additionally, our founder, Chairman and Chief Executive Officer, Chan Heng Fai, directly and indirectly is the owner of an additional 37,947,756 shares of SHRG and is a beneficial owner of approximately 43.5% of SHRG shares (including those shares owned by Alset Inc. and its majority-owned subsidiaries).

 

Consolidation of HWH International Inc. (f.k.a. Alset Capital Acquisition Corp.)

 

On May 1, 2023, HWH International Inc. (then known as Alset Capital Acquisition Corp., or “Alset Capital”) held a Special Meeting of Stockholders. In connection with the Special Meeting and certain amendments to Alset Capital’s Amended and Restated Certificate of Incorporation, 6,648,964 shares of Alset Capital’s Class A Common Stock were rendered for redemption. Following the redemption, 2,449,786 shares of Class A Common Stock of Alset Capital remained issued and outstanding, including 473,750 shares held by the Company. The Company also owns 2,156,250 shares of Alset Capital’s Class B Common Stock. Following the redemptions, Company’s ownership in Alset Capital has increased from 23.4% of the total shares of common stock to 58.0% of the total number of outstanding shares of the two classes. The Company recognized $21,657,036 loss on the consolidation of Alset Capital. The loss is included in Company’s Consolidated Statement of Operations for the year ended December 31, 2023.

 

Business Combination of Alset Capital Acquisition Corp. and HWH International Inc.

 

On January 9, 2024, two entities affiliated with Alset Inc. completed a previously announced transaction. On September 9, 2022, Alset Capital entered into an agreement and plan of merger (the “Merger Agreement”) with our indirect subsidiary HWH International Inc., a Nevada corporation (“HWH”) and HWH Merger Sub Inc., a Nevada corporation and a wholly owned subsidiary of Alset Capital (“Merger Sub”). The Company and its 85.5% owned subsidiary Alset International own Alset Acquisition Sponsor, LLC, the sponsor (the “Sponsor”) of Alset Capital.

 

Pursuant to the Merger Agreement, on January 9, 2024, a business combination between Alset Capital and HWH was effected through the merger of Merger Sub with and into HWH, with HWH surviving the merger as a wholly owned subsidiary of Alset Capital (the “Merger”), and Alset Capital changing its name to HWH International Inc. (“New HWH”).

 

The total consideration paid at the closing of the Merger by New HWH to the HWH shareholders was 12,500,000 shares of New HWH common stock. Alset International owned the majority of the outstanding shares of HWH at the time of the business combination, and received 10,900,000 shares of New HWH as consideration for its shares of HWH.

 

New HWH currently has 16,223,301 shares of common stock issued and outstanding. Of these shares, a total of 13,577,375 shares of New HWH common stock are now owned by the Sponsor and Alset International together. In addition, the Sponsor owns warrants convertible into up to 236,875 shares of New HWH common stock upon exercise.

 

The transaction described above was a transaction between entities under common control. In the transactions under common control, financial statements and financial information were presented as of the beginning of the period as though the assets and liabilities had been transferred at that date. The company controlled both entities and accordingly, the equity was eliminated in consolidation.

 

F-22
 

 

Purchase of Hapi Travel Ltd. Stock

 

On June 14, 2023, the Company’s subsidiary completed acquisition of Hapi Travel Limited (“HTL”), an online travel business started in Hong Kong and under common control of the Company. The accompanying consolidated financial statements include the operations of the acquired entity from its acquisition date. The acquisition has been accounted for as a business combination. Accordingly, consideration paid by the Company to complete the acquisition is initially allocated to the acquired assets and liabilities assumed based upon their estimated fair values on the acquisition date. The recorded amounts for assets acquired and liabilities assumed are provisional and subject to change during the measurement period, which is up to 12 months from the acquisition date. As a result of the acquisition of HTL, a deemed dividend of $214,174 was generated as a result of the business combination, which represents the purchase price of $214,993 in excess of identifiable equity.

 

The common control transaction described above resulted in the following basis of accounting for the financial reporting periods:

 

  The acquisition of HTL was accounted for prospectively as of June 14, 2023 as this did not represent a change in reporting entity.
  The acquisition of HTL was under common control and was consolidated in accordance with ASC 850-50. The Consolidated financial statements were not retrospectively adjusted for the acquisition of HTL as of January 1, 2022 for comparative purposes because the historical operations of HTL were deemed to be immaterial to the Company’s consolidated financial statements.

 

Convertible Notes to Value Exchange

 

On January 27, 2023, the Company and New Electric CV Corporation (together with the Company, the “Lenders”) entered into a Convertible Credit Agreement (the “Credit Agreement”) with VEII. The Credit Agreement provides VEII with a maximum credit line of $1,500,000 with simple interest accrued on any advances of the money under the Credit Agreement at 8%. The Credit Agreement grants conversion rights to each Lender. Each Advance shall be convertible, in whole or in part, into shares of VEII’s Common Stock at the option of the Lender who made that Advance (being referred to as a “Conversion”), at any time and from time to time, at a price per share equal the “Conversion Price”. In the event that a Lender elects to convert any portion of an Advance into shares of VEII Common Stock in lieu of cash payment in satisfaction of that Advance, then VEII would issue to the Lender five (5) detachable warrants for each share of VEII’s Common Stock issued in a Conversion (“Warrants”). Each Warrant will entitle the Lender to purchase one (1) share of Common Stock at a per-share exercise price equal to the Conversion Price. The exercise period of each Warrant will be five (5) years from date of issuance of the Warrant. On February 23, 2023, Hapi Metaverse loaned VEII $1,400,000 (the “Loan Amount”). The Loan Amount can be converted into shares of VEII pursuant to the terms of the Credit Agreement for a period of three years. There is no fixed price for the derivative security until Hapi Metaverse converts the Loan Amount into shares of VEII Common Stock.

 

On September 6, 2023, the Company converted $1,300,000 of the principal amount loaned to VEII into 7,344,632 shares of VEII’s Common Stock. Under the terms of the Credit Agreement, Hapi Metaverse received Warrants to purchase a maximum of 36,723,160 shares of VEII’s Common Stock at an exercise price of $0.1770 per share. Such warrants expire five (5) years from date of their issuance. On March 31, 2024 the fair value of the remaining $100,000 of convertible note and warrants was $28,892 and $877,257, respectively. On December 31, 2023 the fair value of the remaining $100,000 of convertible note and warrants was $101,150 and $2,487,854, respectively. (For further details on fair value valuation refer to Note 12. – Investments Measured at Fair Value, Convertible Note Receivables).

 

On December 14, 2023, Hapi Metaverse entered into a Convertible Credit Agreement (“Credit Agreement”) with VEII. On December 15, 2023, the company loaned VEII $1,000,000. The Credit Agreement was amended pursuant to an agreement dated December 19, 2023. Under the Credit Agreement, as amended, this amount can be converted into VEII’s Common Shares pursuant to the terms of the Credit Agreement for a period of three years. In the event that Hapi Metaverse converts this loan into shares of VEII’s Common Stock, the conversion price shall be $0.045 per share. In the event that Hapi Metaverse elects to convert any portion of the loan into shares of VEII’s Common Stock in lieu of cash payment in satisfaction of that loan, then VEII will issue to Hapi Metaverse five (5) detachable warrants for each share of VEII’s Common Stock issued in a conversion (“Warrants”). Each Warrant will entitle the company to purchase one (1) share of VEII’s Common Stock at a per-share exercise price equal to the Conversion Price. The exercise period of each Warrant will be five (5) years from date of issuance of the Warrant. The fair value of this convertible note on March 31, 2024 and December 31, 2023 was $323,497 and $1,106,477, respectively. (For further details on fair value valuation refer to Note 12. – Investments Measured at Fair Value, Convertible Note Receivables). At the time of this filing, the Company has not converted the Loan Amount.

 

F-23
 

 

Convertible Notes to Sharing Services

 

On January 17, 2024, the Company received a Convertible Promissory Note (the “Convertible Note”) from Sharing Services Global Corp. (“SHRG”), an affiliate of the Company, in exchange for a $250,000 loan made by the Company to SHRG. The Company may convert a portion or all of the outstanding balance due under the Convertible Note into shares of SHRG’s common stock at the average closing market price of SHRG stock within the last three (3) days from the date of conversion notice. The Convertible Note bears a 10% interest rate and has a scheduled maturity six (6) months from the date of the Convertible Note, or July 17, 2024. The fair value of this Convertible Note on March 31, 2024 was $262,782. (For further details on fair value valuation refer to Note 12. – Investments Measured at Fair Value, Convertible Note Receivables).

 

On March 20, 2024, HWH International Inc., a subsidiary of the Company (“HWH”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with SHRG, pursuant to which HWH purchased from SHRG a (i) Convertible Promissory Note in the amount of $250,000, convertible into 208,333,333 shares of SHRG’s common stock at the option of HWH, and (ii) certain warrants exercisable into 208,333,333 shares of SHRG’s common stock at an exercise price of $0.0012 per share, the exercise period of the warrant being five (5) years from the date of the Securities Purchase Agreement, for an aggregate purchase price of $250,000. At the time of filing, HWH has not converted any of the debt contemplated by the Convertible Note nor exercised any of the warrants. On March 31, 2024 the fair value of the convertible note and warrants was $324,521 and $141,667, respectively. (For further details on fair value valuation refer to Note 12. – Investments Measured at Fair Value, Convertible Note Receivables).

 

Advance to Related Party

 

On February 20, 2024, the Company sent $550,000 to Sentinel Brokers Company Inc. (“Sentinel”). The initial purpose of the transfer was to invest in shares of this company. The transaction did not close as planned and the management has not yet decided on the next steps regarding the funds. The Company has significant influence over Sentinel as it holds 11.6% of outstanding shares of Sentinel and its CEO holds a director position on Sentinel’s Board of Directors.

 

Notes Payable

 

Chan Heng Fai provided an interest-free, due on demand advance to SeD Perth Pty. Ltd. for its general operations. As of March 31, 2024 and December 31, 2023, the outstanding balance was $12,165 and $12,716, respectively.

 

Chan Heng Fai provided an interest-free, due on demand advance to Hapi Metaverse Inc. for its general operations. As of March 31, 2024 and December 31, 2023, the outstanding balance was $4,144 and $4,153, respectively.

 

Management Fees

 

MacKenzie Equity Partners, LLC, an entity owned by Charles MacKenzie, a Director of the Company, has a consulting agreement with a majority-owned subsidiary of the Company. Pursuant to an agreement entered into in June of 2022, as supplemented in August, 2023, the Company’s subsidiary has paid $25,000 per month for consulting services. In addition, MacKenzie Equity Partners has been paid certain bonuses, including (i) a sum of $50,000 in June, 2022; (ii) a sum of $50,000 in August 2023; and (iii) a sum of $50,000 in December 2023.

 

The Company incurred expenses of $75,000 and $75,000 in the three months ended March 31, 2024 and 2023, respectively, which were capitalized as part of Real Estate on the balance sheet as the services relate to property and project management. On March 31, 2024 and December 31, 2023, the Company owed this related party $27,535 and $27,535, respectively. These amounts are included in Accounts Payable and Accrued Expenses in the accompanying consolidated balance sheets.

 

Notes Receivable from Related Party

 

On December 31, 2023, the total convertible note receivable from Ketomei, prior to impairment charges, was $368,299. Considering ASC 326 and after reviewing the performance of Ketomei, the Company decided to record 100% impairment for the convertible note receivable and investment in associate in 2023.

 

On June 10, 2021, HCI-T signed a convertible loan agreement with Ketomei, pursuant to which HCI-T has agreed to grant Ketomei a loan of an aggregate principal amount of $75,525 (SG$100,000). On March 21, 2022, HCI-T signed a legally binding term sheet with Ketomei, and HCI-T has agreed to invest in Ketomei $258,186 (SG$350,000) for 28% interest in Ketomei. The investment was partially paid by the $75,525 (SG$100,000) loan borrowed to Ketomei and the accrued interest of $6,022 (SG$6,433). The balance of $183,311 (SG$243,567) was paid in cash.

 

F-24
 

 

On July 28, 2022 HCI-T entered into binding term sheet with Ketomei and Tong Leok Siong Constant, pursuant to which HCI-T lent Ketomei $43,254 (SG$60,000). This loan had a 0% interest rate for the first 60 days and an interest rate of 8% per annum afterwards.

 

On August 4, 2022, the same parties entered into another binding term sheet (the “Second Term Sheet”) pursuant to which HCI-T agreed to lend Ketomei up to $260,600 (SG$360,000) pursuant to a convertible loan, with a term of 12 months. After the initial 12 months, the interest on such loan will be 8%. As of August 31, 2023, the $263,766 (SG$360,000) loan was paid by the $214,903 (SG$293,310) loan borrowed to Ketomei and $48,862 (SG$66,690) was paid for the expenses on behalf of Ketomei. In addition, pursuant to the Second Term Sheet, the July 28, 2022, loan was modified to include conversion rights. The Parties agree that the conversion rate will be at approximately $0.022 per share.

 

On August 31, 2023, the same parties entered into another binding term sheet pursuant to which HCI-T agreed to lend Ketomei up to $36,634 (SG$50,000) pursuant to a convertible loan, with a term of 12 months. After the initial 12 months, the interest on such loan will be 3.5%. As of October 31, 2023, the $37,876 (SG$50,000) loan was paid to Ketomei.

 

On October 26, 2023, the same parties entered into another binding term sheet pursuant to which HCI-T agreed to lend Ketomei up to $37,876 (SG$50,000) pursuant to a non- convertible loan, with a term of 12 months. After the initial 12 months, the interest on such loan will be 3.5%. As of December 31, 2023, the $6,766 (SG$8,932) loan was paid to Ketomei. HCI-T will pay the balance of $31,110 (SG$41,068) to Ketomei in the future.

 

The amount due from Ketomei at December 31, 2023 was $0.

 

On February 20, 2024, HCI-T invested $312,064 (SG$420,000) for an additional 38.41% ownership interest in Ketomei by converting $312,064 of convertible loan. The loan was impaired at the year ended of December 31, 2023, therefore, $312,064 was transferred from impairment of convertible loan to impairment of equity method investment. After this additional investment, Hapi Cafe owns 55.65% (the Company owns indirectly 41%) of Ketomei’s outstanding shares and Ketomei is consolidated into the financial statements of HWH International Inc. beginning on February 20, 2024.

 

On October 13, 2021 BMI Capital Partners International Limited (“BMI”) entered into loan agreement with Liquid Value Asset Management Limited (“LVAML”), a subsidiary of DSS, pursuant to which BMI agreed to lend $3,000,000 to LVAML. The loan has variable interest rate and matured on January 12, 2023, with automatic three-month extension. The purpose of the loan is to purchase a portfolio of trading securities by LVAM. BMI participates in the losses and gains from portfolio based on the calculations included in the loan agreement. As of March 31, 2024 and December 31, 2023 LVAML owes the Company $491,087 and $534,671, respectively.

 

On September 28, 2023 Alset International Limited (“Alset International”) entered into loan agreement with Value Exchange International Inc., pursuant to which Alset International agreed to lend $500,000 to VEII. The loan carries simple annual interest rate of 8%. As of March 31, 2024 and December 31, 2023 the Company accrued $20,000 and $10,000 interest, respectively, and VEII owed $520,000 and $510,000, respectively to Alset International.

 

8. GOODWILL

 

The Company continually evaluates potential acquisitions that align with the Company’s plans, namely, starting the F&B business in Asia. Starting an F&B business in Hong Kong, China, and Taiwan can be an excellent opportunity due to the large consumer market, diverse food culture, high demand for international cuisine, favorable business environment, skilled labor force, and opportunities for growth. On October 4, 2022, The Company has completed its first F&B business acquisition of MOC HK Limited (“MOC”), a F&B business started in Hong Kong. The accompanying consolidated financial statements include the operations of the acquired entity from its acquisition date. The acquisition has been accounted for as a business combination. Accordingly, consideration paid by the Company to complete the acquisition is initially allocated to the acquired assets and liabilities assumed based upon their estimated acquisition date fair values.

 

As a result of the acquisition of MOC, goodwill of $60,343 generated in a business combination represents the purchase price of $70,523 in excess of identifiable tangible and intangible assets. Goodwill and intangible assets that have an indefinite useful life are not amortized. Instead, they are reviewed periodically for impairment.

 

F-25
 

 

The Company evaluates goodwill on an annual basis in the fourth quarter or more frequently if management believes indicators of impairment exist. Such indicators could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. If management concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, management conducts a quantitative goodwill impairment test. The impairment test involves comparing the fair value of the applicable reporting unit with its carrying value. The Company estimates the fair values of its reporting units using a combination of the income, or discounted cash flows, approach and the market approach, which utilizes comparable companies’ data. If the carrying amount of a reporting unit exceeds the reporting unit’s fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The Company’s evaluation of goodwill completed during the year resulted in no impairment losses.

 

The following table summarizes changes in the carrying amount of goodwill for the three months ended March 31, 2024 and the years ended December 31, 2023.

 

   March 31, 2024   December 31, 2023 
         
Balance at beginning of the year  $60,273   $60,343 
Foreign currency exchange adjustment   (124)   (70)
Balance as of end of the year  $60,149   $60,273 

 

9. EQUITY

 

On June 14, 2021, the Company filed an amendment (the “Amendment”) to its Third Amended and Restated Certificate of Incorporation, as amended, to increase the Company’s authorized share capital. The Amendment increased the Company’s authorized share capital to 250,000,000 common shares and 25,000,000 preferred shares, from 20,000,000 common shares and 5,000,000 preferred shares, respectively.

 

The Company has designated 6,380 preferred shares as Series A Preferred Stock and 2,132 as Series B Preferred Stock.

 

On December 6, 2022 the Company filed a certificate of Amendment to the Company’s Certificate of Formation with the Texas Secretary of State to effect a 1-for-20 reverse stock split. The reverse stock split was effective as of December 28, 2022.

 

Holders of the Series A Preferred Stock shall be entitled to receive dividends equal, on an as-if-converted basis, to and in the same form as dividends actually paid on shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) when, as and if paid on shares of Common Stock. Each holder of outstanding Series A Preferred Stock is entitled to vote equal to the number of whole shares of Common Stock into which each share of the Series A Preferred Stock is convertible. Holders of Series A Preferred Stock are entitled, upon liquidation of the Company, to receive the same amount that a holder of Series A Preferred Stock would receive if the Series A Preferred Stock were fully converted into Common Stock.

 

Holders of the Series B Preferred Stock shall be entitled to receive dividends equal, on an as-if-converted basis, to and in the same form as dividends actually paid on shares of the Company’s common stock par value $0.001 per share (“Common Stock”) when, as and if paid on shares of Common Stock. Each holder of outstanding Series B Preferred Stock is entitled to vote equal to the number of whole shares of Common Stock into which each share of the Series B Preferred Stock is convertible. Holders of Series B Preferred Stock are entitled, upon liquidation of the Company, to receive the same amount that a holder of Series B Preferred Stock would receive if the Series B Preferred Stock were fully converted into Common Stock.

 

F-26
 

 

The Company analyzed the Preferred stock and the embedded conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option should be classified as equity.

 

On February 6, 2023, the Company entered into an Underwriting Agreement (the “Underwriting Agreement”) in connection with an offering (the “Offering”) of its common stock, par value $0.001 per share (the “Common Stock”), with Aegis Capital Corp. (the “Underwriter”) as the underwriter, relating to an underwritten public offering of 1,727,273 shares of Common Stock at a public offering price of $2.20 per share. The Underwriting Agreement provides the Underwriter a 45-day option to purchase up to an additional 212,863 shares of Common Stock to cover over-allotments, if any.

 

The net proceeds to the Company from the Offering were approximately $3.3 million, after deducting underwriting discounts and the payment of other offering expenses associated with the Offering that are payable by the Company.

 

The Offering closed on February 8, 2023. The Common Stock was being offered pursuant to an effective registration statement on Form S-3 (File No. 333-264234), as well as a prospectus supplement in connection with the Offering filed with the Securities and Exchange Commission.

 

On March 31, 2024, there were 9,235,119 common shares issued and outstanding.

 

The following table summarizes the warrant activity for the three months ended March 31, 2024.

 

  

Warrant for

Common

Shares

  

Weighted

Average

Exercise Price

  

Remaining Contractual

Term

(Years)

  

Aggregate

Intrinsic

Value

 
Warrants Outstanding as of December 31, 2023   603,051   $80.46    2.37   $- 
Warrants Vested and exercisable at December 31, 2023   603,051   $80.46    2.37   $- 
Granted   -    -           
Exercised   -    -           
Forfeited, cancelled, expired   -    -           
Warrants Outstanding as of March 31, 2024   603,051   $80.46    2.12   $- 
Warrants Vested and exercisable at March 31, 2024   603,051   $80.46    2.12   $       - 

 

Class A Common Stock of HWH International Inc. Subject to Possible Redemption

 

The Company accounts for its, and its subsidiaries’ common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity”. Common stock subject to possible redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2023, the Class A common stock of HWH International Inc. subject to possible redemption in the amount of $20,457,011, are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets. On March 31, 2024, following redemptions and closing of business combination the temporary equity is $0.

 

On May 1, 2023, after the redemptions (for further details on this transaction refer to Note 7. – Related Party Transactions, Consolidation of HWH International Inc.), the Company consolidated HWH International Inc.

 

Issuance of HWH Shares to EF Hutton

 

On December 18, 2023, the Company’s subsidiary, HWH International Inc. (“HWH”) entered into a Satisfaction and Discharge of Indebtedness Agreement in connection with an underwriting agreement previously entered into by HWH and EF Hutton, a division of Benchmark Investments, LLC, under which in lieu of HWH tendering the full amount due of $3,018,750, the underwriters accepted a combination of $325,000 in cash upon the closing of the business combination, 149,443 shares of the Company’s common stock and a $1,184,375 promissory note as full satisfaction. This agreement was effective at the closing of business combination on January 9, 2024. The 149,443 shares were issued as of the price of $10.10, totaling the amount of $1,509,375. The fair value of the HWH shares at issuance on January 9, 2024 was $2.82 per share or $421,429. No gain or loss was recognized upon issuance of the shares on January 9, 2024 as this was an adjustment to prior underwriting costs accounted for in equity.

 

F-27
 

 

10. LEASE INCOME

 

The Company generally rents its SFRs under lease agreements with a term of one or two years. Future minimum rental revenue under existing leases on our properties at March 31, 2024 in each calendar year through the end of their terms are as follows:

 

      
2024   1,330,956 
2025   230,034 
Total Future Receipts  $1,560,990 

 

Property Management Agreements

 

The Company has entered into property management agreement with the property managers under which the property managers generally oversee and direct the leasing, management and advertising of the properties in our portfolio, including collecting rents and acting as liaison with the tenants. The Company pays its property managers a monthly property management fee for each property unit and a leasing fee. For the three months ended March 31, 2024 and 2023, property management fees incurred by the property managers were $35,010 and $31,950, respectively. For the three months ended March 31, 2024 and 2023, leasing fees incurred by the property managers were $10,260 and $25,010, respectively.

 

11. ACCUMULATED OTHER COMPREHENSIVE INCOME

 

Following is a summary of the changes in the balances of accumulated other comprehensive income, net of tax, for the three months ended March 31, 2024 and 2023:

 

   Unrealized Gains and Losses on Security Investment   Foreign Currency Translations   Change in Minority Interest   Total 
Balance at January 1, 2024  $(54,921)  $(119,566)  $3,784,206   $3,609,719 
                     
Other Comprehensive Loss   -    (992,871)   (13,888)   (1,006,759)
                     
Balance at March 31, 2024  $(54,921)  $(1,112,437)  $3,770,318   $2,602,960 

 

   Unrealized Gains and Losses on Security Investment   Foreign Currency Translations   Change in Minority Interest   Total 
Balance at January 1, 2023  $(54,921)  $121,272   $3,769,712   $3,836,063 
                     
Other Comprehensive Income   -    936,265    -    936,265 
                     
Balance at March 31, 2023  $(54,921)  $1,057,537   $3,769,712   $4,772,328 

 

F-28
 

 

12. INVESTMENTS MEASURED AT FAIR VALUE

 

Financial assets measured at fair value on a recurring basis are summarized below and disclosed on the condensed consolidated balance sheet as of March 31, 2024 and December 31, 2023:

   Fair Value Measurement Using   Amount at 
   Level 1   Level 2   Level 3   Fair Value 
March 31, 2024                    
Assets                    
Investment Securities- Fair Value Option  $5,684,510   $945,306   $-   $6,629,816 
Investment Securities- Trading   703,160    2,040,978    -    2,744,138 
Warrants - NECV   -    -    973    973 
Warrants - VEII   -    877,257    -    877,257 
Warrants - SHRG   -    141,667    -    141,667 
Convertible Loan Receivable - VEII   -    352,389    -    352,389 
Convertible Loan Receivable - SHRG   -    587,303    -    587,303 
                     
Total Investment in Securities at Fair Value  $6,387,670   $4,944,900   $973   $11,333,543 

 

   Fair Value Measurement Using   Amount at 
   Level 1   Level 2   Level 3   Fair Value 
December 31, 2023                    
Assets                    
Investment Securities- Fair Value Option  $7,537,472   $2,100,720   $-   $9,638,192 
Investment Securities- Trading   35,036    1,779,601    -    1,814,637 
Convertible Note Receivable   -    -    77,307    77,307 
Warrants - NECV   -    -    430    430 
Warrants - VEII   -    2,487,854    -    2,487,854 
Convertible Loan Receivable - VEII   -    1,207,627    -    1,207,627 
                     
Total Investment in securities at Fair Value  $7,572,508   $7,575,802   $77,737   $15,226,047 

 

Realized loss on investment securities for the three months ended March 31, 2024 and 2023 was $152,468 and $131,313, respectively. Unrealized loss on securities investment was $5,265,817 and $1,187,846 in the three months ended March 31, 2024 and 2023, respectively. These losses were recorded directly to net loss.

 

For U.S. trading stocks, we use Bloomberg Market stock prices as the share prices to calculate fair value. For overseas stock, we use the stock price from the local stock exchange to calculate fair value. The following chart shows details of the fair value of equity security investment at March 31, 2024 and December 31, 2023, respectively.

   Share price       Market Value    
   3/31/2024   Shares   3/31/2024   Valuation
                
DSS (Related Party)  $1.810    3,140,613   $5,684,510   Investment in Securities at Fair Value – Related Party
                   
Trading Stocks            $703,160   Investment in Securities at Fair Value
                   
    Total Level 1 Equity Securities    $6,387,670    
                   
AMBS  $0.000    20,000,000   $2,000   Investment in Securities at Fair Value
                   
Holista  $0.007    36,199,845   $236,122   Investment in Securities at Fair Value
                   
New Electric CV (Related Party)  $0.000    354,039,000   $0   Investment in Securities at Fair Value – Related Party
                   
Value Exchange (Related Party)  $0.024    21,179,275   $506,185   Investment in Securities at Fair Value – Related Party
                   
Sharing Services (Related Party)  $0.002    125,624,528   $200,999   Investment in Securities at Fair Value – Related Party
                   
Trading Stocks            $2,040,978   Investment in Securities at Fair Value
                   
    Total Level 2 Equity Securities    $2,986,284    
Nervotec   N/A    1,666   $36,999   Investment in Securities at Cost
UBeauty   N/A    3,600   $16,602   Investment in Securities at Cost
    Total Equity Securities    $9,427,554    

 

F-29
 

 

   Share price       Market Value    
   12/31/2023   Shares   12/31/2023   Valuation
                
DSS (Related Party)  $0.120    62,812,264   $7,537,472   Investment in Securities at Fair Value – Related Party
                   
Trading Stocks            $35,036   Investment in Securities at Fair Value
                   
    Total Level 1 Equity Securities   $7,572,508    
                   
AMBS  $0.001    20,000,000   $10,000   Investment in Securities at Fair Value
                   
Holista  $0.007    36,159,845   $246,556   Investment in Securities at Fair Value
                   
New Electric CV (Related Party)  $0.000    354,039,000   $0   Investment in Securities at Fair Value – Related Party
                   
Value Exchange (Related Party)  $0.067    21,179,275   $1,429,602   Investment in Securities at Fair Value – Related Party
                   
Sharing Services (Related Party)  $0.003    125,624,528   $414,562   Investment in Securities at Fair Value – Related Party
                   
Trading Stocks            $1,779,601   Investment in Securities at Fair Value
                   
    Total Level 2 Equity Securities   $3,880,321    
                   
Nervotec   N/A    1,666   $37,876   Investment in Securities at Cost
UBeauty   N/A    3,600   $16,636   Investment in Securities at Cost
    Total Equity Securities   $11,507,341    

 

Changes in the observable input values would likely cause material changes in the fair value of the Company’s Level 3 financial instruments. A significant increase (decrease) in this likelihood would result in a higher (lower) fair value measurement.

 

The table below provides a summary of the changes in fair value which are recorded as other comprehensive income (loss), including net transfers in and/or out of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024 and 2023:

   Total 
Balance at January 1, 2024  $77,737 
Impairment   (77,307)
Total Gains   543 
Total gains   543 
Balance at March 31, 2024  $973 

 

   Total 
Balance at January 1, 2023  $416,164 
Total gains   62,348 
Balance at March 31, 2023  $478,512 

 

Vector Com Convertible Bond

 

On February 26, 2021, the Company invested approximately $88,599 in the convertible note of Vector Com Co., Ltd (“Vector Com”), a private company in South Korea. The interest rate is 2% per annum. The conversion price is approximately $21.26 per common share of Vector Com. As of December 31, 2023, the Management estimated the fair value of the note to be $88,599. The Company wrote off this loan at March 31, 2024

 

F-30
 

 

Warrants

 

NECV

 

On July 17, 2020, the Company purchased 122,039,000 shares, approximately 9.99% ownership, and 1,220,390,000 warrants with an exercise price of $0.0001 per share, from NECV, for an aggregated purchase price of $122,039. During 2021, the Company exercised 232,000,000 of the warrants to purchase 232,000,000 shares of NECV for the total consideration of $232,000, leaving the balance of outstanding warrants of 988,390,000 at December 31, 2022. The Company did not exercise any warrants during three months ended March 31, 2024 and the year ended December 31, 2023. We value NECV warrants under level 3 category through a Black Scholes option pricing model and the fair value of the warrants from NECV was $973 as of March 31, 2024 and $430 as of December 31, 2023.

 

The fair value of the NECV warrants under level 3 category as of March 31, 2024 and December 31, 2023 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:

SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

  

March 31,

2024

  

December 31,

2023

 
         
Stock Price  $0.0001   $0.0001 
Exercise price   0.001    0.001 
Risk free interest rate   4.62%   4.62%
Annualized volatility   869.4%   869.4%
Dividend Yield   0.00    0.00 
Year to maturity   6.31    6.56 

 

VEII

 

On September 6, 2023, the Company received warrants to purchase shares of VEII, a related party listed company. For further details on this transaction, refer to Note 7 - Related Party Transactions, Note Receivable from a Related Party Company. As of March 31, 2024 and December 31, 2023, the fair value of the warrants was $877,257 and $2,487,854, respectively. The Company did not exercise any warrants during the three months ended March 31, 2024 and the year ended December 31, 2023.

 

The fair value of the VEII warrants under level 2 category as of March 31, 2024, and December 31, 2023 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:

  

March 31,

2024

  

December 31,

2023

 
         
Stock price  $0.0240   $0.0677 
Exercise price   0.1770    0.1770 
Risk free interest rate   8.50%   8.50%
Annualized volatility   291.68%   275.85%
Dividend Yield  $0.00   $0.00 
Year to maturity   4.43    4.68 

 

SHRG

 

On March 20, 2024, HWH International Inc., a subsidiary of the Company (“HWH”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with SHRG, pursuant to which HWH purchased from SHRG a (i) Convertible Promissory Note in the amount of $250,000, convertible into 208,333,333 shares of SHRG’s common stock at the option of HWH, and (ii) certain warrants exercisable into 208,333,333 shares of SHRG’s common stock at an exercise price of $0.0012 per share, the exercise period of the warrant being five (5) years from the date of the Securities Purchase Agreement, for an aggregate purchase price of $250,000. At the time of filing, HWH has not converted any of the debt contemplated by the Convertible Note nor exercised any of the warrants.

 

The fair value of the SHRG warrants under level 2 category as of March 31, 2024, was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:

  

March 31, 2024

 
     
Stock price  $0.0016 
Exercise price   0.0012 
Risk free interest rate   4.22%
Annualized volatility   136.81%
Dividend Yield  $0.00 
Year to maturity   4.96 

 

Convertible Loan Receivables

 

The Company has elected to recognize the convertible loan receivables at fair value and therefore there was no further evaluation of embedded features for bifurcation. The Company engaged third party valuation firm to perform the valuation of convertible loans. The fair value of the convertible loans is calculated using the binomial tree model based on probability of remaining as straight debt using discounted cash flow.

 

F-31
 

 

13. COMMITMENTS AND CONTINGENCIES

 

Lots Sales Agreement

 

Ballenger Project

 

Certain arrangements for the sale of buildable lots to NVR require the Company to credit NVR with an amount equal to one year of the FFB assessment. Under ASC 606, the credits to NVR are not in exchange for a distinct good or service and accordingly, the amount of the credit was recognized as the reduction of revenue. As of March 31, 2024 and December 31, 2023, the accrued balance due to NVR was $189,475.

 

Lakes at Black Oak Project

 

  - Agreement to Sell 142 Lots and 63 Lots

 

On November 13, 2023, 150 CCM Black Oak Ltd. (the “Seller”), a Texas Limited Partnership, entered into two Contracts for Purchase and Sale and Escrow Instructions (each an “Agreement,” collectively, the “Agreements”) with Century Land Holdings of Texas, LLC, a Colorado limited liability company (the “Buyer”). Pursuant to the terms of one of the aforementioned Agreements, the Seller has agreed to sell approximately 142 single-family detached residential lots comprising a section of a residential community in the city of Magnolia, Texas known as the “Lakes at Black Oak.” The selling price of these lots is anticipated to equal approximately $7.4 million. Pursuant to the other Agreement, the Seller has agreed to sell 63 single-family detached residential lots in the city of Magnolia, Texas. In 2021, our subsidiary Alset EHome Inc. acquired approximately 19.5 acres of partially developed land near Houston, Texas which was used to develop a community named Alset Villas (“Alset Villas”). Alset EHome was in the process of developing the 63 lots at Alset Villas in 2023. The selling price of these lots is anticipated to equal approximately $3.3 million. The closing of the transactions described above depends on the satisfaction of certain conditions, and is expected to take place during the second quarter of 2024.

 

Leases

 

The Company leases offices in Maryland, Singapore, Texas, Hong Kong, South Korea and China through leased spaces aggregating approximately 30,000 square feet, under leases expiring on various dates from June 2024 to March 2027. The leases have rental rates ranging from $283 to $23,020 per month. Our total rent expense under these office leases was $292,719 and $259,678 in the three months ended March 31, 2024 and 2023, respectively. Total cash paid for operating leases was $319,302 and $272,844 for the three months ended March 31, 2024 and 2023, respectively. The following table outlines the details of lease terms:

Office Location   Lease Term as of December 31, 2023
Singapore - AI   June 2023 to May 2026
Singapore – F&B   October 2021 to September 2024
Singapore – Four Seasons Park   July 2022 to July 2024
Singapore – Hapi Cafe   July 2022 to June 2024
Singapore - PLQ   December 2022 to July 2024
Hong Kong - Office   October 2022 to October 2024
Hong Kong - Warehouse   November 2022 to October 2024
Hong Kong - Shop   October 2022 to September 2024
Hong Kong – Hapi Travel   September 2023 to August 2025
South Korea – Hapi Cafe   August 2022 to August 2025
South Korea – HWH World   August 2022 to July 2025
Bethesda, Maryland   April 2024 to March 2027
China - Cafe   December 2023 - November 2024
China - Office   March 2023 – March 2027

 

F-32
 

 

The Company adopted ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) to recognize a right-of-use asset and a lease liability for all the leases with terms greater than twelve months. We elected the practical expedient to not recognize operating lease right-of-use assets and operating lease liabilities for lease agreements with terms less than 12 months. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As our leases do not provide a readily determinable implicit rates, we estimate our incremental borrowing rates to discount the lease payments based on information available at lease commencement. Our incremental borrowings rates are at a range from 0.35% to 7.22% per annum in the three months ended March 31, 2024 and December 31, 2023, which were used as the discount rates. At March 31, 2024 the weighted average remaining lease term is 1.97 years and weighted average discount rate is 4.36. The balances of operating lease right-of-use assets and operating lease liabilities as of March 31, 2024 were $1,514,903 and $1,548,903. The balances of operating lease right-of-use assets and operating lease liabilities as of December 31, 2023 were $1,467,372 and $1,499,263, respectively.

 

The table below summarizes future payments due under these leases as of March 31, 2024.

 

For the Years Ended March 31:

      
2025   914,534 
2026   487,775 
2027   213,026 
Total Minimum Lease Payments  $1,615,335 
Less: Effect of Discounting   (66,433)
Present Value of Future Minimum Lease Payments   1,548,903 
Less: Current Obligations under Leases   (577,836)
Long-term Lease Obligations  $971,067 

 

Security Deposits

 

Our rental-home lease agreements require tenants to provide a one-month security deposits. The property management company collects all security deposits and maintains them in a trust account. The Company also has obligation to refund these deposits to the renters at the time of lease termination. As of March 31, 2024 and December 31, 2023, the security deposits held in the trust account were $304,598 and $309,688, respectively.

 

14. DIRECTORS AND EMPLOYEES’ BENEFITS

 

AEI Stock Option plans

 

Under our 2018 Incentive Compensation Plan (the “Plan”), adopted by our board of directors and holders of a majority of our outstanding shares of common stock in September 2018, 25,000 shares of common stock (subject to certain adjustments) were reserved for issuance upon exercise of stock options and grants of other equity awards. No options or other equity awards have been granted under the Plan. The reservation of shares under the Incentive Compensation Plan was cancelled in May 2021.

 

Alset International Stock Option plans

 

On November 20, 2013, Alset International approved a Stock Option Plan (the “2013 Plan”). Employees, executive directors, and non-executive directors (including the independent directors) are eligible to participate in the 2013 Plan.

 

The following tables summarize stock option activity under the 2013 Plan for the three months ended March 31, 2024:

   Options for Common Shares   Exercise Price   Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
Outstanding as of January 1, 2023   1,061,333   $0.09    1.00   $       - 
Vested and exercisable at January 1, 2023   1,061,333   $0.09    1.00   $- 
Granted   -    -           
Exercised   -    -           
Forfeited, cancelled, expired   (1,061,333)  $0.09           
Outstanding as of December 31, 2023   -   $-    0.00   $- 
Vested and exercisable at December 31, 2023   -   $-    0.00   $- 
Granted   -    -           
Exercised   -    -           
Forfeited, cancelled, expired   -    -           
Outstanding as of March 31, 2024   -   $-    0.00   $- 
Vested and exercisable at March 31, 2024   -   $-    0.00   $- 

 

15. SUBSEQUENT EVENTS

 

Joint Venture

 

On April 25, 2024, the Company’s subsidiary, HWH International Inc. (“HWH”) entered into a binding term sheet through its subsidiary Health Wealth Happiness Pte Ltd. (“HWHPL”) outlining a joint venture with Chen Ziping, an experienced entrepreneur in the travel industry, and Chan Heng Fai Ambrose, the Company’s Chairman and Chief Executive Officer and HWH’s Executive Chairman, as a part of HWH’s strategy of building its travel business in Asia. The planned joint venture company (referred to here as the “JVC”) will be known as HapiTravel Holding Pte. Ltd. The JVC will be initially owned as follows: (a) HWHPL will hold 19% of the shares in the JVC; (b) Mr. Chan will hold 11%; and (c) the remaining 70% of the shares in the JVC are to be held by Mr. Chen.

 

F-33
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

This Form 10-Q contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may”, “will”, “expect”, “believe”, “anticipate”, “estimate” or “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include by are not limited to economic conditions generally and in the industries in which we may participate, competition within our chosen industry, including competition from much larger competitors, technological advances and failure to successfully develop business relationships.

 

Business Overview

 

We are a diversified holding company principally engaged through our subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities and consumer products with operations in the United States, Singapore, Hong Kong, Australia and South Korea. We manage our three principal businesses primarily through our 85.5% owned subsidiary, Alset International, a public company traded on the Singapore Stock Exchange. Through this subsidiary (and indirectly, through other public and private U.S. and Asian subsidiaries), we are actively developing real estate projects near Houston, Texas in our real estate segment. In our digital transformation technology segment, we focus on serving business-to-business (B2B) needs in e-commerce, collaboration and social networking functions. Our biohealth segment includes the sale of consumer products.

 

We also have ownership interests outside of Alset International, including a 36.9% equity interest in American Pacific Financial, Inc., formerly known as American Pacific Bancorp Inc. (“APF”), an indirect 13% equity interest in Holista CollTech Limited (“Holista”), a 44.4% equity interest in DSS Inc. (“DSS”), an indirect 48.7% equity interest in Value Exchange International Inc. (“VEII”), a 0.5% equity interest in New Electric CV Corporation (“NECV”, formerly known as “American Wealth Mining Inc.”) and a 33.4% equity interest in Sharing Services Global Corporation (“SHRG”). APF is a financial network holding company. Holista is a public Australian company that produces natural food ingredients (ASX: HCT). DSS is a multinational company operating businesses within nine divisions: product packaging, biotechnology, direct marketing, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy. DSS is listed on the NYSE American (NYSE: DSS). VEII is a provider of information technology services for businesses, and is traded on the OTCQB (OTCQB: VEII). NECV is a publicly traded consumer products company (OTCPK: HIPH). SHRG markets and distributes health and wellness products, as well as member-based travel services, using a direct selling business model. SHRG is traded on the OTCQB (OTCQB: SHRG).

 

We generally acquire majority and/or control stakes in innovative and promising businesses that are expected to appreciate in value over time. Our emphasis is on building businesses in industries where our management team has in-depth knowledge and experience, or where our management can provide value by advising on new markets and expansion. We have at times provided a range of global capital and management services to these companies in order to gain access to Asian markets. We have historically favored businesses that improve an individual’s quality of life or that improve the efficiency of businesses through technology in various industries. We believe our capital and management services provide us with a competitive advantage in the selection of strategic acquisitions, which creates and adds value for our company and our stockholders.

 

Recent Developments

 

Consummation of the Merger of Alset Capital Acquisition Corp. and HWH International Inc.

 

On January 9, 2024, two entities affiliated with Alset Inc. completed a previously announced transaction. On September 9, 2022, Alset Capital Acquisition Corp., a Delaware corporation (“Alset Capital”) entered into an agreement and plan of merger (the “Merger Agreement”) with our indirect subsidiary HWH International Inc., a Nevada corporation (“HWH”) and HWH Merger Sub Inc., a Nevada corporation and a wholly owned subsidiary of Alset Capital (“Merger Sub”). The Company and its 85.5% owned subsidiary Alset International own Alset Acquisition Sponsor, LLC, the sponsor (the “Sponsor”) of Alset Capital.

 

Pursuant to the Merger Agreement, on January 9, 2024, a business combination between Alset Capital and HWH was effected through the merger of Merger Sub with and into HWH, with HWH surviving the merger as a wholly owned subsidiary of Alset Capital (the “Merger”), and Alset Capital changing its name to HWH International Inc. (“New HWH”).

 

3
 

 

The total consideration paid at the closing of the Merger by New HWH to the HWH shareholders was 12,500,000 shares of New HWH common stock. Alset International owned the majority of the outstanding shares of HWH at the time of the business combination, and received 10,900,000 shares of New HWH as consideration for its shares of HWH.

 

New HWH currently has 16,223,301 shares of common stock issued and outstanding. Of these shares, a total of 13,577,375 shares of New HWH common stock are now owned by the Sponsor and Alset International together. In addition, the Sponsor owns warrants convertible into up to 236,875 shares of New HWH common stock upon exercise.

 

New HWH is in the midst of implementing the new membership model described below (the “New Model”), that operates on a yearly subscription basis. New HWH intends to resume membership sales, albeit under the New Model, in approximately 2nd quarter of 2024.

 

HWH Members get exclusive discounts on HWH Marketplace products, priority invites to product launch events and other parties, and can earn passive income when a member’s referral signs up for membership or makes an initial purchase through the HWH Marketplace products through them.

 

Purchase of Rental Business from Majority-Owned Subsidiary

 

On December 9, 2022, Alset Inc. entered into an agreement with Alset EHome Inc. and Alset International pursuant to which Alset Inc. agreed to reorganize the ownership of its home rental business. Previously, Alset Inc. and certain majority-owned subsidiaries collectively owned 132 single-family rental homes in Texas. 112 of these rental homes are owned by subsidiaries of American Home REIT Inc. (“AHR”). Alset Inc. owns 85.5% of Alset International, and Alset International indirectly owns approximately 99.9% of Alset EHome Inc.

 

The closing of the transaction contemplated by this agreement was completed on January 13, 2023. Pursuant to this agreement, Alset Inc. has become the direct owner of AHR and its subsidiaries that collectively own these 112 homes, instead of such homes being owned indirectly through Alset International’s subsidiaries.

 

Alset EHome Inc. sold AHR to Alset Inc. for a total consideration of $26,250,933, including the forgiveness of debt in the amount of $13,900,000, a promissory note in the amount of $11,350,933 and a cash payment of $1,000,000. This purchase price represents the book value of AHR as of November 30, 2022.

 

The closing of this transaction was approved by the shareholders of Alset International and the transaction was closed on January 13, 2023. Certain members of Alset Inc.’s Board of Directors and management are also members of the Board of Directors and management of each of Alset International and Alset EHome Inc.

 

Public Offering

 

On February 6, 2023, we entered into an Underwriting Agreement (the “Underwriting Agreement”) in connection with an offering (the “Offering”) of our common stock, par value $0.001 per share (the “Common Stock”), with Aegis Capital Corp. (the “Underwriter”) as the underwriter, relating to an underwritten public offering of 1,727,273 shares of Common Stock at a public offering price of $2.20 per share. The Underwriting Agreement provides the Underwriter a 45-day option to purchase up to an additional 212,863 shares of Common Stock to cover over-allotments, if any.

 

The net proceeds to the Company from the Offering were approximately $3.3 million, after deducting underwriting discounts and the payment of other offering expenses associated with the Offering that are payable by the Company.

 

4
 

 

The Offering closed on February 8, 2023. The Common Stock was being offered pursuant to an effective registration statement on Form S-3 (File No. 333-264234), as well as a prospectus supplement in connection with the Offering filed with the Securities and Exchange Commission.

 

Purchase of Travel Business

 

On June 14, 2023, the Company’s subsidiary completed acquisition of Hapi Travel Limited (“HTL”), an online travel business started in Hong Kong and under common control of the Company. The accompanying consolidated financial statements include the operations of the acquired entity from its acquisition date. The acquisition has been accounted for as a business combination. Accordingly, consideration paid by the Company to complete the acquisition is initially allocated to the acquired assets and liabilities assumed based upon their estimated fair values on the acquisition date. The recorded amounts for assets acquired and liabilities assumed are provisional and subject to change during the measurement period, which is up to 12 months from the acquisition date. As a result of the acquisition of HTL, a deemed dividend of $214,174 was generated as a result of the business combination, which represents the purchase price of $214,993 in excess of identifiable equity.

 

The common control transaction described above resulted in the following basis of accounting for the financial reporting periods:

 

  The acquisition of HTL was accounted for prospectively as of June 14, 2023 as this did not represent a change in reporting entity.
  The acquisition of HTL was under common control and was consolidated in accordance with ASC 850-50. The Consolidated financial statements were not retrospectively adjusted for the acquisition of HTL as of January 1, 2022 for comparative purposes because the historical operations of HTL were deemed to be immaterial to the Company’s consolidated financial statements.

 

Purchase of Sentinel Brokers Company Inc. Shares

 

On May 22, 2023 the Company’s indirect subsidiary, SeD Capital Pte Ltd (“SeD Capital”), entered into a Stock Purchase Agreement, pursuant to which SeD Capital purchased 39.8 shares (11.6%) of the Common Stock of Sentinel Brokers Company Inc. (“Sentinel”) for the aggregate purchase price of $279,719. Sentinel is a broker-dealer operating primarily as a fiduciary intermediary, facilitating institutional trading of municipal and corporate bonds as well as preferred stock, and is registered with the Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”), and is a member of the Securities Investor Protection Corporation (“SIPC”). The Company has significant influence over Sentinel and its CEO holds a director position on Sentinel’s Board of Directors.

 

Sale of Certain Lots

 

Sale of 131 Lots

 

On October 28, 2022, 150 CCM Black Oak Ltd. (the “Seller”), a Texas Limited Partnership and subsidiary of the Company, entered into a Contract for Purchase and Sale and Escrow Instructions (the “Agreement”) with Century Land Holdings of Texas, LLC, a Colorado limited liability company (the “Buyer”). Pursuant to the terms of the Agreement, the Seller agreed to sell approximately 242 single-family detached residential lots comprising a residential community in the city of Magnolia, Texas known as the “Lakes at Black Oak.” On November 28, 2022, the parties to the Agreement entered into an amendment to the Agreement (the “Amendment”). Pursuant to the Amendment, the parties agreed that the Buyer would purchase approximately 131 single-family detached residential lots, instead of 242 lots. This transaction closed on April 13, 2023.

 

5
 

 

Agreement to Sell 110 Lots

 

On March 16, 2023, 150 CCM Black Oak Ltd. (the “Seller”) entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”) with Rausch Coleman Homes Houston, LLC, a Texas limited liability company (“Rausch Coleman”). Pursuant to the terms of the Purchase and Sale Agreement, the Seller has agreed to sell approximately 110 single-family detached residential lots which comprise a section of the Lakes at Black Oak. The transaction closed on May 15, 2023.

 

Agreement to Sell 189 Lots

 

On March 17, 2023, 150 CCM Black Oak Ltd. (the “Seller”) entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”) with Davidson Homes, LLC, an Alabama limited liability company (“Davidson”). Pursuant to the terms of the Purchase and Sale Agreement, the Seller had agreed to sell approximately 189 single-family detached residential lots developed within section 2 of Lakes at Black Oak project. The sale of the first 94 lots closed on May 30, 2023. The sale of remaining lots closed on January 4, 2024.

 

Issuance of Convertible Loans to Value Exchange International, Inc.

 

On January 27, 2023, the Company and New Electric CV Corporation (together with the Company, the “Lenders”) entered into a Convertible Credit Agreement (the “Credit Agreement”) with VEII. The Credit Agreement provides VEII with a maximum credit line of $1,500,000 with simple interest accrued on any advances of the money under the Credit Agreement at 8%. The Credit Agreement grants conversion rights to each Lender. Each Advance shall be convertible, in whole or in part, into shares of VEII’s Common Stock at the option of the Lender who made that Advance (being referred to as a “Conversion”), at any time and from time to time, at a price per share equal the “Conversion Price”. In the event that a Lender elects to convert any portion of an Advance into shares of VEII Common Stock in lieu of cash payment in satisfaction of that Advance, then VEII would issue to the Lender five (5) detachable warrants for each share of VEII’s Common Stock issued in a Conversion (“Warrants”). Each Warrant will entitle the Lender to purchase one (1) share of Common Stock at a per-share exercise price equal to the Conversion Price. The exercise period of each Warrant will be five (5) years from date of issuance of the Warrant. On February 23, 2023, Hapi Metaverse loaned VEII $1,400,000 (the “Loan Amount”). The Loan Amount can be converted into shares of VEII pursuant to the terms of the Credit Agreement for a period of three years. There is no fixed price for the derivative security until Hapi Metaverse converts the Loan Amount into shares of VEII Common Stock.

 

On September 6, 2023, the Company converted $1,300,000 of the principal amount loaned to VEII into 7,344,632 shares of VEII’s Common Stock. Under the terms of the Credit Agreement, Hapi Metaverse received Warrants to purchase a maximum of 36,723,160 shares of VEII’s Common Stock at an exercise price of $0.1770 per share. Such warrants expire five (5) years from date of their issuance.

 

On December 14, 2023, Hapi Metaverse entered into a Convertible Credit Agreement (“Credit Agreement”) with VEII. On December 15, 2023, the company loaned VEII $1,000,000. The Credit Agreement was amended pursuant to an agreement dated December 19, 2023. Under the Credit Agreement, as amended, this amount can be converted into VEII’s Common Shares pursuant to the terms of the Credit Agreement for a period of three years. In the event that Hapi Metaverse converts this loan into shares of VEII’s Common Stock, the conversion price shall be $0.045 per share. In the event that Hapi Metaverse elects to convert any portion of the loan into shares of VEII’s Common Stock in lieu of cash payment in satisfaction of that loan, then VEII will issue to Hapi Metaverse five (5) detachable warrants for each share of VEII’s Common Stock issued in a conversion (“Warrants”). Each Warrant will entitle the company to purchase one (1) share of VEII’s Common Stock at a per-share exercise price equal to the Conversion Price. The exercise period of each Warrant will be five (5) years from date of issuance of the Warrant. At the time of this filing, the company has not converted the Loan Amount.

 

The Company currently owns a total of 21,179,275 shares (representing approximately 48.7%) of VEII.

 

Mr. Chan and another member of the Board of Directors of Hapi Metaverse, Lum Kan Fai Vincent, are both members of the Board of Directors of VEII. In addition to Mr. Chan, two other members of the Board of Directors of Alset Inc. are also members of the Board of Directors of VEII (Mr. Wong Shui Yeung and Mr. Wong Tat Keung).

 

6
 

 

SHRG Shares Dividend Received from DSS

 

On May 4, 2023, DSS distributed approximately 280 million shares of Sharing Services Global Corporation (“SHRG”) beneficially held by DSS and its subsidiaries in the form of a dividend to the shareholders of DSS common stock. As a result of this distribution, the Company directly received 70,426,832 shares of SHRG, and through its majority-owned subsidiary Alset International, and certain subsidiaries of Alset International, indirectly received additional 55,197,696 shares of SHRG. The Company and its majority-owned subsidiaries now collectively own 125,624,528 shares of SHRG, representing 33.4% of the issued and outstanding shares of SHRG Common Stock (such number of SHRG shares held and ownership percentage do not include any shares held by affiliates of the Company which we do not hold a majority interest in). Additionally, our founder, Chairman and Chief Executive Officer, Chan Heng Fai, directly and indirectly is the owner of an additional 37,947,756 shares of SHRG and is a beneficial owner of approximately 43.5% of SHRG shares (including those shares owned by Alset Inc. and its majority-owned subsidiaries).

 

Issuance of Convertible Loans to Sharing Services Global Corp.

 

On January 17, 2024, the Company received a Convertible Promissory Note (the “Convertible Note”) from Sharing Services Global Corp. (“SHRG”), an affiliate of the Company, in exchange for a $250,000 loan made by the Company to SHRG. The Company may convert a portion or all of the outstanding balance due under the Convertible Note into shares of SHRG’s common stock at the average closing market price of SHRG stock within the last three (3) days from the date of conversion notice. The Convertible Note bears a 10% interest rate and has a scheduled maturity six (6) months from the date of the Convertible Note, or July 17, 2024.

 

On March 20, 2024, HWH International Inc., a subsidiary of the Company (“HWH”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with SHRG, pursuant to which HWH purchased from SHRG a (i) Convertible Promissory Note in the amount of $250,000, convertible into 208,333,333 shares of SHRG’s common stock at the option of HWH, and (ii) certain warrants exercisable into 208,333,333 shares of SHRG’s common stock at an exercise price of $0.0012 per share, the exercise period of the warrant being five (5) years from the date of the Securities Purchase Agreement, for an aggregate purchase price of $250,000. At the time of filing, HWH has not converted any of the debt contemplated by the Convertible Note nor exercised any of the warrants.

 

Resignation of Chief Operating Officer

 

On March 10, 2024, Anthony S. Chan resigned as Chief Operating Officer of Alset Inc. (the “Company”), effective immediately, due to personal reasons. Mr. Chan’s resignation is not the result of any disagreement with the Company. Mr. Chan remains as a consultant to the Company.

 

Matters that May or Are Currently Affecting Our Business

 

In addition to the matters described above, the primary challenges and trends that could affect or are affecting our financial results include:

 

● Our ability to improve our revenue through cross-selling and revenue-sharing arrangements among our diverse group of companies;

 

● Our ability to identify complementary businesses for acquisition, obtain additional financing for these acquisitions, if and when needed, and profitably integrate them into our existing operation;

 

● Our ability to attract competent, skilled technical and sales personnel for each of our businesses at acceptable compensation levels to manage our overhead;

 

● Our ability to control our operating expenses as we expand each of our businesses and product and service offerings; and

 

● The effects of public health issues such as a major epidemic or pandemic, including the impact of COVID-19 on the economy and our business.

 

7
 

 

Results of Operations

 

Summary of Statements of Operations for the Three Months Ended March 31, 2024 and 2023

 

   Three- Months Ended 
   March 31, 2024   March 31, 2023 
Revenue  $6,086,207   $926,936 
Operating Expenses  $(8,352,720)  $(3,016,666)
Other Expenses  $(5,047,279)  $(2,233,452)
Income Tax Expense   -    - 
Net Loss  $(7,313,792)  $(4,323,182)

 

Revenue

 

The following tables set forth period-over-period changes in revenue for each of our reporting segments:

 

   Three-months Ended   Change 
   March 31, 2024   March 31, 2023   Dollars   Percentage 
Real Estate  $5,752,994   $633,811   $5,119,183    808%
Biohealth   535    12,786    (12,251)   -96%
Digital Transformation Technology   -    14,040    (14,040)   -100%
Other   332,678    266,299    66,379    25%
Total Revenue  $6,086,207   $926,936   $5,159,271    557%

 

Revenue was $6,086,207 and $926,936 for the three months ended March 31, 2024 and 2023, respectively. The increase in property sales from the Lakes at Black Oak Project in the first three months of 2024 contributed to higher revenue in this period.

 

The Company plans to continue its near-term focus on lot sales to regional and national builders. Funds from such lot sales will substantially improve the Company’s liquidity, strengthen its financial position and meet is working capital requirements.

 

Revenue from rental business was $707,592 and $633,811 in the three months ended March 31, 2024 and 2023, respectively. The Company expects that the revenue from this business will continue to increase as we acquire more rental houses and successfully rent them.

 

In May 2023, the Company entered into lease agreement for one of its model houses located in Montgomery County, Texas. The revenue from the lease was $6,300 in the three months ended March 31, 2024.

 

In January 2024, the Company entered into lease agreement for another model house located in Montgomery County, Texas. The revenue from the lease was $6,602 in the three months ended March 31, 2024.

 

In recent years, the Company expanded its biohealth segment to the South Korean market through one of the subsidiaries of HWH International Inc., HWH World Inc (“HWH World”). HWH World operates based on a direct sale model of health supplements. HWH World recognized $535 and $ 12,786 in revenue in the three months ended March 31, 2024 and 2023, respectively.

 

The category described as “Other” includes corporate and financial services, food and beverage business and new venture businesses. “Other” includes certain costs that are not allocated to the reportable segments, primarily consisting of unallocated corporate overhead costs, including administrative functions not allocated to the reportable segments from global functional expenses.

 

The financial services, food and beverage businesses and new venture businesses are small and diversified, and accordingly they are not separately addressed as one independent category. In the three months ended March 31, 2024 and 2023, the revenue from other businesses was $332,678 and $1,083,971, respectively, generated by Korean, Singaporean and Chinese café shops and restaurants.

 

8
 

 

Cost of Revenues and Operating Expenses

 

The following tables sets forth period-over-period changes in cost of revenues for each of our reporting segments:

 

   Three-months Ended   Change 
   March 31, 2024   March 31, 2023   Dollars   Percentage 
Real Estate  $4,533,660   $602,340   $3,931,320    653%
Biohealth   2,041    14,367    (12,326)   -86%
Digital Transformation Technology   -    4,568    (4,568)   -100%
Other   122,666    68,006    54,660    80%
Total Cost of Revenues  $4,658,367   $689,281   $3,969,086    576%

 

Cost of revenues increased from $689,281 in the three months ended March 31, 2023 to $4,658,367 in the three months ended March 31, 2024. The increase is a result of the increase in sales in the Lakes at Black Oak Project. Capitalized construction expenses, finance costs and land costs are allocated to sales. We anticipate the total cost of revenues to increase as revenue increases.

 

The gross margin increased from $237,655 to $1,427,840 in the three months ended March 31, 2023 and 2024, respectively. The increase of gross margin was caused by the increase in sales in the Lakes at Black Oak Project.

 

The following tables sets forth period-over-period changes in operating expenses for each of our reporting segments.

 

   Three-months Ended   Change 
   March 31, 2024   March 31, 2023   Dollars   Percentage 
Real Estate  $361,696   $440,017   $(78,321)   -18%
Biohealth   826,961    141,290    685,671    485%
Digital Transformation Technology   163,707    139,903    23,804    17%
Other   2,341,990    1,606,175    735,815    46%
Total Operating Expenses  $3,694,354   $2,327,385   $1,366,969    59%

 

The increase of operating expenses in the first three months of 2024 compared to the same period of 2023 was mostly caused by recording of goodwill and investment.

 

Other Income (Expense)

 

In the three months ended March 31, 2024, the Company had other expenses of $5,047,279 compared to other expenses of $2,233,452 in the three months ended March 31, 2023. The gain on sale of stock of subsidiary and foreign exchange transaction gain are the primary reason for the volatility in these two periods. Gain on the sale of stock of subsidiary was $15,695,977 in the three months ended March 31, 2024, compared to $0 gain in the three months ended March 31, 2023. Foreign exchange transaction gain was $1,193,636 the three months ended March 31, 2024, compared to a loss of $788,302 in the three months ended March 31, 2023.

 

Net Loss

 

In the three months ended March 31, 2024 the Company had net loss of $7,313,792 compared to net loss of $4,323,182 in the three months ended March 31, 2023.

 

9
 

 

Liquidity and Capital Resources

 

Our real estate assets have decreased to $39,883,629 as of March 31, 2024 from $42,137,152 as of December 31, 2023. This decrease reflects the sale of multiple lots in Lakes at Black Oak project during first three months of 2024.

 

Our cash has decreased from $26,921,727 as of December 31, 2023 to $23,727,542 as of March 31, 2024. Our liabilities decreased from $9,066,700 at December 31, 2023 to $6,670,132 at March 31, 2024. Our total assets have decreased to $96,710,288 as of March 31, 2024 from $126,314,028 as of December 31, 2023 mainly due to decrease in cash held in Trust Account after shareholders of HWH International Inc. redeemed their shares.

 

On April 17, 2019, SeD Maryland Development LLC entered into a Development Loan Agreement with Manufacturers and Traders Trust Company (“M&T Bank”) in the principal amount not to exceed at any one time outstanding the sum of $8,000,000, with a cumulative loan advance amount of $18,500,000. The line of credit bore interest rate on LIBOR plus 375 basis points. SeD Maryland Development LLC was also provided with a Letter of Credit (“L/C”) Facility in an aggregate amount of up to $900,000. The L/C commission will be 1.5% per annum on the face amount of the L/C. Other standard lender fees will apply in the event the L/C is drawn down. The loan is a revolving line of credit. The L/C Facility is not a revolving loan, and amounts advanced and repaid may not be re-borrowed. Repayment of the Loan Agreement is secured by a $2,600,000 collateral fund and a Deed of Trust issued to the Lender on the property owned by SeD Maryland. On March 15, 2022, approximately $2,300,000 was released from collateral, leaving approximately $300,000 as collateral for outstanding letters of credit. On December 14, 2023 approximately $201,751 was released from collateral, leaving approximately $100,000 as collateral for outstanding letters of credit.

 

The future development timeline of Lakes at Black Oak will be based on multiple conditions, including the amount of funds which may be raised from capital markets, the loans we may secure from third party financial institutions, and government reimbursements which may be received. The development will be step by step and expenses will be contingent on the amount of funding we will receive.

 

On November 13, 2023, 150 CCM Black Oak Ltd. (the “Seller”), a Texas Limited Partnership, entered into two Contracts for Purchase and Sale and Escrow Instructions (each an “Agreement,” collectively, the “Agreements”) with Century Land Holdings of Texas, LLC, a Colorado limited liability company (the “Buyer”). Pursuant to the terms of one of the aforementioned Agreements, the Seller has agreed to sell approximately 142 single-family detached residential lots (the “Section 4 Agreement”) comprising a section of a residential community in the city of Magnolia, Texas known as the “Lakes at Black Oak.” The selling price of these lots is anticipated to equal approximately $7.4 million. Pursuant to the other Agreement, the Seller has agreed to sell 63 single-family detached residential lots (the “Alset Villas Agreement”) in the city of Magnolia, Texas. In 2021, our subsidiary Alset EHome Inc. acquired approximately 19.5 acres of partially developed land near Houston, Texas which was used to develop a community named Alset Villas (“Alset Villas”). Alset EHome was in the process of developing the 63 lots at Alset Villas in 2023. The selling price of these lots is anticipated to equal approximately $3.3 million. The closing of the transactions described above depends on the satisfaction of certain conditions, and is expected to take place during the second quarter of 2024. In addition, the Company will be entitled to receive certain reimbursements in the year ended December 31, 2024 and 2025.

 

The management believes that the available cash in bank accounts and favorable cash revenue from real estate projects are sufficient to fund our operations for at least the next 12 months.

 

Summary of Cash Flows for the Three Months Ended March 31, 2024 and 2023

 

   Three-months Ended 
   2024   2023 
Net cash used in operating activities  $(1,509,247)  $(3,289,083)
Net cash (used in) provided by investing activities  $(1,758,503)  $671,484 
Net cash (used in) provided by financing activities  $(240,182)  $3,433,921 

 

10
 

 

Cash Flows from Operating Activities

 

Net cash used in operating activities was $1,509,247 in the first three months of 2024, as compared to net cash used operating activities of $3,289,083 in the same period of 2023. Capitalization of real estate expenses was the main reason for the cash used in operating activities in 2023. Prepayment of expenses and investment in trading securities were the main reason for the cash used in 2024

 

Cash Flows from Investing Activities

 

Net cash used in investing activities was $1,758,503 in the first three months of 2024, as compared to net cash provided by investing activities of $671,484 in the same period of 2023. In the three months ended March 31, 2024 we invested $646,785 in marketable securities, issued $1,144,317 in loans to related parties and received $34,671 from repayment of related party notes receivable. In the three months ended March 31, 2023 we invested $412,500 in marketable securities, issued $1,521,368 in loans to related parties and received $2,613,629 from repayment of related party notes receivable.

 

Cash Flows from Financing Activities

 

Net cash used in financing activities was $240,182 in the three months ended March 31, 2024, compared to net cash provided of $3,433,921 in the three months ended March 31, 2023. In the first three months of 2024 the Company borrowed $119,621 from a third part loan and repaid $359,803 of note payable. The cash provided by financing activities in the first three months of 2023 is caused by the proceeds from stock issuance of $3,433,921.

 

Impact of Inflation

 

We believe that inflation has not had a material impact on our results of operations for the three months ended March 31, 2024 or the year ended December 31, 2023. We cannot assure you that future inflation will not have an adverse impact on our operating results and financial condition.

 

Impact of Foreign Exchange Rates

 

The effect of foreign exchange rate changes on the intercompany loans (under ASC 830), which mostly consist of loans from Singapore to the United States and which were approximately $23 million and $23 million on March 31, 2024 and December 31, 2023, respectively, are the reason for the significant fluctuation of foreign currency transaction Gain or Loss on the Condensed Consolidated Statements of Operations and Other Comprehensive Loss. Because the intercompany loan balances between Singapore and United States will remain at approximately $23 million over the next year, we expect this fluctuation of foreign exchange rates to still significantly impact the results of operations in 2024, especially given that the foreign exchange rate may and is expected to be volatile. If the amount of intercompany loan is lowered in the future, the effect will also be reduced. However, at this moment, we do not expect to repay the intercompany loans in the short term.

 

Emerging Growth Company Status

 

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies.” Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of these exemptions until we are no longer an emerging growth company or until we affirmatively and irrevocably opt out of this exemption.

 

Seasonality

 

The real estate business is subject to seasonal shifts in costs as certain work is more likely to be performed at certain times of the year. This may impact the expenses of our subsidiary Alset EHome Inc. from time to time. In addition, should we commence building homes, we are likely to experience periodic spikes in sales as we commence the sales process at a particular location.

 

11
 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

As a “smaller reporting company” as defined by Item 10(f)(1) of Regulation S-K, the Company is not required to provide the information required by this Item.

 

Item 4. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officers and Chief Financial Officers, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our management, including our Chief Executive Officers and Chief Financial Officers, concluded that our disclosure controls and procedures are not effective as of March 31, 2024 to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officers and Chief Financial Officers, as appropriate to allow timely decisions regarding required disclosure.

 

(b) Changes in the Company’s Internal Controls Over Financial Reporting

 

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15(d)-15(f) under the Exchange Act) that occurred during the quarterly period ended March 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Part II. Other Information

 

Item 1. Legal Proceeding

 

Not applicable.

 

Item 1A. Risk Factors

 

Not applicable to smaller reporting companies.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Not applicable.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

Not applicable.

 

12
 

 

Item 6. Exhibits

 

The following documents are filed as a part of this report:

 

Exhibit Number  

 

Description

31.1a*   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.1b*   Certification of Co-Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2a*   Certification of Co-Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2b*   Certification of Co-Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**   Certifications of the Chief Executive Officer and Chief Financial Officers pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.
** Furnished herewith.

 

13
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ALSET INC.
     
May 15, 2024 By: /s/ Chan Heng Fai
   

Chan Heng Fai

Chairman of the Board and

Chief Executive Officer

    (Principal Executive Officer)
     
May 15, 2024 By: /s/ Chan Tung Moe
    Chan Tung Moe
    Co-Chief Executive Officer
    (Principal Executive Officer)
     
May 15, 2024 By: /s/ Rongguo Wei
   

Rongguo Wei

Co-Chief Financial Officer

    (Principal Financial and Accounting Officer)
     
May 15, 2024 By: /s/ Lui Wai Leung Alan
   

Lui Wai Leung Alan

Co-Chief Financial Officer

    (Principal Financial and Accounting Officer)

 

14